博士（医学）, 信州大学

ライフサイエンス, 消化器内科学 , 消化器内科学

2008年
信州大学（医学部） 教授

2007年 - 2008年
信州大学（医学部） 准教授

2001年 - 2007年
信州大学（医学部） 助教授

1995年 - 2001年
信州大学（医学部） 講師

1988年 - 1995年
信州大学（医学部） 助手

1982年, 信州大学, 医学研究科

1978年, 金沢大学, 医学部

評議員, 日本内科学会

財団評議員, 日本消化器病学会

理事, 日本肝臓学会

Correlation of clinicopathological features and LGR5 expression in colon adenocarcinoma
Sato K, Uehara T, Iwaya M, Nakajima T, Miyagawa Y, Ota H, Tanaka E
Ann Diagn Pathol, 48, 151587, 2020年10月
最終著者

Pilot study of tenofovir disoproxil fumarate and pegylated interferon-alpha 2a add-on therapy in Japanese patients with chronic hepatitis B
Matsumoto A, Nishiguchi S, Enomoto H, Tanaka Y, Shinkai N, Okuse C, Kang JH, Matsui T, Miyase S, Yatsuhashi H, Nagaoka S, Kanda T, Enomoto M, Yamada R, Hiramatsu N, Saito S, Takaguchi K, Ito K, Masaki T, Morihara D, Tsuge M, Chayama K, Ikeda F, Kagawa T, Kondo Y, Murata K, Tanaka E
J Gastroenterol, 55(10), 977-989, 2020年10月
最終著者

Clinical impact of normal alanine aminotransferase on direct-acting antiviral outcome in patients with chronic hepatitis C virus infection
Joshita S, Sugiura A, Umemura T, Yamazaki T, Fujimori N, Matsumoto A, Usami Y, Tanaka E
JGH Open, 4(4), 574-581, 2020年08月
最終著者

Long-term luseogliflozin therapy improves histological activity of non-alcoholic steatohepatitis accompanied by type 2 diabetes mellitus
Fujimori N, Tanaka N, Kimura T, Sano K, Horiuchi A, Kato N, Takahashi Y, Kuribayashi N, Sugiura A, Yamazaki T, Joshita S, Umemura T, Matsumoto A, Tanaka E
Clin J Gastroenterol, 13(1), 83-89, 2020年02月
最終著者

Diffuse large B-cell lymphoma of the colon and rectum in a patient with colonic Crohn's disease treated with infliximab and azathioprine
Sato K, Suga T, Hirayama A, Daikuhara S, Uehara T, Tanaka E
Clin J Gastroenterol, 13(1), 1-5, 2020年02月
最終著者

Virological Factors Associated With the Occurrence of Hepatitis B Virus (HBV) Reactivation in Patients With Resolved HBV Infection Analyzed Through Ultradeep Sequencing
Sakamoto K, Umemura T, Ito K, Okumura A, Joshita S, Ota M, Sugiyama M, Mizokami M, Yoneda M, Tanaka E
J Infect Dis, 221(3), 2020年01月
最終著者

【内科医が知っておくべき肝移植の実際】脳死肝移植レシピエントの適応と選択　令和になっての改訂
田中榮司
消化器・肝臓内科, 7(3), 231-237, 2020年
筆頭著者

既存抗ウイルス療法の限界
田中榮司
臨床消化器内科, 35(2), 125-126, 2020年
筆頭著者

胆嚢癌との鑑別が困難な画像所見を呈した胆嚢線維性ポリープの1例
芦原典宏, 渡邉貴之, 倉石康弘, 小澤真希子, 中村晃, 金井圭太, 大月聡明, 浜野英明, 田中榮司
胆道, 33(5), 854-861, 2019年12月

Clinical utility of FibroScan as a non-invasive diagnostic test for primary biliary cholangitis
Joshita S, Yamashita Y, Sugiura A, Uehara T, Usami Y, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E, Umemura T
J Gastroenterol Hepatol, 2019年11月

KIR/HLA genotypes confer susceptibility and progression in patients with autoimmune hepatitis
Umemura T, Joshita S, Saito H, Yoshizawa K, Norman GL, Tanaka E, Ota M
JHEP Rep, 1(5), 353-360, 2019年11月

Correlation of clinicopathological features and leucine-rich repeat-containing G-protein-coupled receptor 5 expression in pancreatic ductal adenocarcinoma
Kuraishi Y, Uehara T, Kobayashi Y, Nakajima T, Watanabe T, Shimizu A, Ota H, Tanaka E:
Pathol Res Pract, 215(11), 152623, 2019年11月

Biochemical and plasma lipid responses to pemafibrate in patients with primary biliary cholangitis
Joshita S, Umemura T, Yamashita Y, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E
Hepatol Res, 49(10), 1236-1243, 2019年10月

嚢胞周囲に限局した自己免疫性膵炎の1例
小澤真希子, 渡邉貴之, 芦原典宏, 倉石康弘, 中村晃, 金井圭太, 松本有機, 小林実喜子, 田中榮司
膵臓, 34(5), 239-246, 2019年10月

Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society
Umeshita K, Eguchi S, Egawa H, Haga H, Kasahara M, Kokudo N, Sakisaka S, Takada Y, Tanaka E, Eguchi H, Uemoto S, Ohdan H
Hepatol Res, 49(9), 964-980, 2019年09月

Efficacy and safety of eradication therapy for elderly patients with helicobacter pylori infection
Kobayashi S, Joshita S, Yamamoto C, Yanagisawa T, Miyazawa T, Miyazawa M, Kubota D, Sato J, Umemura T, Tanaka E
Medicine (Baltimore), 98(30), e16619, 2019年07月

What will happen in patients with advanced nonalcoholic fatty liver
Kimura T, Tanaka N, Tanaka E
Hepatobiliary Surg Nutr, 8(3), 283-285, 2019年06月

Response to the letter by Matsushita et al. regarding our manuscript "Resection Depth and Layer of Cold Snare Polypectomy versus Endoscopic Mucosal Resection"
Suga T, Ito A, Ota H, Tateiwa N, Matsumoto A, Tanaka E
J Gastroenterol, 54(5), 473, 2019年05月

【肝臓病学の未来-ウイルス性肝炎から脂肪肝と肝がんの時代へ】NAFLD/NASH　期待される新薬
田中直樹, 木村岳史, 藤森尚之, 田中榮司
内科, 123(5), 1155-1158, 2019年05月

Red plasma and ascites under ultraviolet A
Wakabayashi SI, Kimura T, Tanaka N, Komatsu M, Tanaka E
Lancet Gastroenterol Hepatol, 4(4), 324, 2019年04月

A Case of Adult T-Cell Leukemia/Lymphoma Complicated with Bilateral Chylothorax
Kako S, Joshita S, Matsuo A, Kawaguchi K, Umemura T, Tanaka E
Case Rep Oncol Med, 8357893, 2019年03月

Renal impairment is associated with increased risk of mortality in patients with cirrhosis: A retrospective cohort study
Umemura T, Joshita S, Shibata S, Sugiura A, Yamazaki T, Fujimori N, Matsumoto A, Tanaka E
Medicine (Baltimore), 98(6), e14475, 2019年02月

【消化器癌の危険因子・予防対策】 肝臓癌のリスクファクターと予防対策　肝炎ウイルス以外
田中直樹, 木村岳史, 藤森尚之, 田中榮司
消化器・肝臓内科, 5(2), 215-221, 2019年02月

ウイルス肝炎と歩んだ40年
田中榮司
信州医学雑誌, 67(1), 27-30, 2019年02月

Current status, problems, and perspectives of non-alcoholic fatty liver disease research
Tanaka N, Kimura T, Fujimori N, Nagaya T, Komatsu M, Tanaka E
World J Gastroenterol, 25(2), 163-177, 2019年01月

Miglitol attenuates non-alcoholic steatohepatitis in diabetic patients
Komatsu M, Tanaka N, Kimura T, Fujimori N, Sano K, Horiuchi A, Sugiura A, Yamazaki T, Shibata S, Joshita S, Umemura T, Matsumoto A, Tanaka E
Hepatol Res, 48(13), 1092-1098, 2018年12月

Past history of hepatocellular carcinoma is an independent risk factor of treatment failure in patients with chronic hepatitis C virus infection receiving direct-acting antivirals
Sugiura A, Joshita S, Umemura T, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Usami Y, Wada S, Mori H, Shibata S, Yoshizawa K, Morita S, Furuta K, Kamijo A, Iijima A, Kako S, Maruyama A, Kobayashi M, Komatsu M, Matsumura M, Miyabayashi C, Ichijo T, Takeuchi A, Koike Y, Gibo Y, Tsukadaira T, Inada H, Kiyosawa K, Tanaka E
J Viral Hepat, 25(12), 1462-1471, 2018年12月

Resection depth and layer of cold snare polypectomy versus endoscopic mucosal resection
Ito A, Suga T, Ota H, Tateiwa N, Matsumoto A, Tanaka E
J Gastroenterol, 53(11), 1171-1178, 2018年11月

Quantitative analysis of serum chemokines associated with treatment failure of direct-acting antivirals in chronic hepatitis C
Umemura T, Yamazaki T, Joshita S, Sugiura A, Fujimori N, Matsumoto A, Ota M, Tanaka E
CYTOKINE, 111, 357-363, 2018年10月

Emergence of anti-mitochondrial M2 antibody in patient with angioimmunoblastic T-cell lymphoma
Wakabayashi SI, Kimura T, Tanaka N, Joshita S, Kawata K, Umemura T, Hiroshima Y, Mori H, Kobayashi H, Wada S, Tanaka E
Clin J Gastroenterol, 11(4), 302-308, 2018年08月

A cis-eQTL of HLA-DPB1 Affects Susceptibility to Type 1 Autoimmune Hepatitis
Yamazaki T, Umemura T, Joshita S, Yoshizawa K, Tanaka E, Ota M
Sci Rep, 8(1), 11924, 2018年08月

Hepatic Angiosarcoma with Kasabach-Merritt Phenomenon: A Case Report and Review of the Literature
Fujii F, Kimura T, Tanaka N, Kubota D, Sugiura A, Umemura T, Wada S, Tanaka E
Ann Hepatol, 17(4), 655-660, 2018年07月

Accuracy of Endoscopic Diagnosis for Mild Atrophic Gastritis Infected with Helicobacter pylori
Okamura T, Iwaya Y, Kitahara K, Suga T, Tanaka E
Clin Endosc, 51(4), 362-367, 2018年07月

Serum Autotaxin Is a Useful Disease Progression Marker in Patients with Primary Biliary Cholangitis
Joshita S, Umemura T, Usami Y, Yamashita Y, Norman GL, Sugiura A, Yamazaki T, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Yoshizawa K, Ota M, Tanaka E
Sci Rep, 8(1), 8159, 2018年05月

Genome-wide association study identified new susceptible genetic variants in HLA class I region for hepatitis B virus-related hepatocellular carcinoma
Sawai H, Nishida N, Khor SS, Honda M, Sugiyama M, Baba N, Yamada K, Sawada N, Tsugane S, Koike K, Kondo Y, Yatsuhashi H, Nagaoka S, Taketomi A, Fukai M, Kurosaki M, Izumi N, Kang JH, Murata K, Hino K, Nishina S, Matsumoto A, Tanaka E, Sakamoto N, Ogawa K, Yamamoto K, Tamori A, Yokosuka O, Kanda T, Sakaida I, Itoh Y, Eguchi Y, Oeda S, Mochida S, Yuen MF, Seto WK, Poovorawan Y, Posuwan N, Mizokami M, Tokunaga K
Sci Rep, 8(1), 7958, 2018年05月

A case of liver abscess co-infected with Desulfovibrio desulfuricans and Escherichia coli and review of the literature
Yamazaki T, Joshita S, Kasuga E, Horiuchi K, Sugiura A, Fujimori N, Komatsu M, Umemura T, Matsumoto A, Tanaka E
J Infect Chemother, 24(5), 393-397, 2018年05月

Mild drinking habit is a risk factor for hepatocarcinogenesis in non-alcoholic fatty liver disease with advanced fibrosis
Kimura T, Tanaka N, Fujimori N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Umemura T, Matsumoto A, Tanaka E
World J Gastroenterol, 24(13), 1440-1450, 2018年04月

KIR2DL2 combined with HLA-C1 confers risk of hepatitis C virus-related hepatocellular carcinoma in younger patients
Saito H, Umemura T, Joshita S, Yamazaki T, Fujimori N, Kimura T, Komatsu M, Matsumoto A, Tanaka E, Ota M
Oncotarget, 9(28), 19650-19661, 2018年04月

Serum autotaxin levels are correlated with hepatic fibrosis and ballooning in patients with non-alcoholic fatty liver disease
Fujimori N, Umemura T, Kimura T, Tanaka N, Sugiura A, Yamazaki T, Joshita S, Komatsu M, Usami Y, Sano K, Igarashi K, Matsumoto A, Tanaka E
World J Gastroenterol, 24(11), 1239-1249, 2018年03月

Serum autotaxin is a useful liver fibrosis marker in patients with chronic hepatitis B virus infection
Joshita S, Ichikawa Y, Umemura T, Usami Y, Sugiura A, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Igarashi K, Ota M, Tanaka E
Hepatol Res, 48(4), 275-285, 2018年03月

Living donor liver transplantation for biliary atresia: An analysis of 2085 cases in the registry of the Japanese Liver Transplantation Society
Kasahara M, Umeshita K, Sakamoto S, Fukuda A, Furukawa H, Sakisaka S, Kobayashi E, Tanaka E, Inomata Y, Kawasaki S, Shimada M, Kokudo N, Egawa H, Ohdan H, Uemoto S
Am J Transplant, 18(3), 659-668, 2018年03月

長期経過加療中の非肝硬変期に肝細胞癌を合併した原発性胆汁性胆管炎の２例
杉浦亜弓, 城下智, 山下裕騎, 木村岳史, 山崎智生, 藤森尚之, 小松通治, 松本晶博, 小林翔太, 梅村武司, 田中榮司
信州医学雑誌, 66(1), 39-49, 2018年02月10日

Genetics and epigenetics in the pathogenesis of primary biliary cholangitis
Joshita S, Umemura T, Tanaka E, Ota M
Clin J Gastroenterol, 11(1), 11-18, 2018年02月

Combinational use of hepatitis B viral antigens predicts responses to nucleos(t)ide analogue/peg-interferon sequential therapy
Matsumoto A, Nishiguchi S, Enomoto H, Kang JH, Tanaka Y, Shinkai N, Kurosaki M, Enomoto M, Kanda T, Yokosuka O, Yatsuhashi H, Nagaoka S, Okuse C, Kagawa T, Mine T, Takaguchi K, Saito S, Hino K, Ikeda F, Sakisaka S, Morihara D, Miyase S, Tsuge M, Chayama K, Hiramatsu N, Suzuki Y, Murata K, Tanaka E
J Gastroenterol, 53(2), 247-257, 2018年02月

Induction of IFN-lambda3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection
Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M
Gut, 67(2), 362-371, 2018年02月

Salmonella Enteritidis cholecystitis with chronic granulomatous disease
Yamashita Y, Kimura T, Tanaka N, Yazaki M, Itagaki T, Joshita S, Umemura T, Matsumoto A, Mori H, Wada S, Tanaka E
IDCases, 12, 49-52, 2018年

Association between KIR-HLA combination and ulcerative colitis and Crohn's disease in a Japanese population
Saito H, Hirayama A, Umemura T, Joshita S, Mukawa K, Suga T, Tanaka E, Ota M
PLOS ONE, 13(4), e0195778, 2018年

Changes in serum levels of autotaxin with direct-acting antiviral therapy in patients with chronic hepatitis C
Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Kimura T, Matsumoto A, Igarashi K, Ota M, Tanaka E
PLOS ONE, 13(4), e0195632, 2018年

Association of autoimmune hepatitis with Src homology 2 adaptor protein 3 gene polymorphisms in Japanese patients
Umemura T, Joshita S, Hamano H, Yoshizawa K, Kawa S, Tanaka E, Ota M
J Hum Genet, 62(11), 963-967, 2017年11月

Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury
Fujimori N, Komatsu M, Tanaka N, Iwaya M, Nakano H, Sugiura A, Yamazaki T, Shibata S, Iwaya Y, Muraki T, Ichikawa Y, Kimura T, Joshita S, Umemura T, Matsumoto A, Tanaka E
Clin J Gastroenterol, 10(5), 452-458, 2017年10月

Survival in patients with Child-Pugh class C cirrhosis: Analysis of the liver transplant registry in Japan
Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y, The Assessment Committee of Indication for Transplantation
Hepatol Res, 47(11), 1155-1164, 2017年10月

Association between lower air pressure and the onset of ischemic colitis: a case-control study
Kimura T, Shinji A, Tanaka N, Koinuma M, Yamaura M, Nagaya T, Joshita S, Komatsu M, Umemura T, Horiuchi A, Wada S, Tanaka E
Eur J Gastroenterol Hepatol, 29(9), 1071-1078, 2017年09月

【ウイルス肝炎のすべて】血液伝播するウイルス肝炎 B型肝炎　B型肝炎に対する核酸アナログ/インターフェロン併用療法
梅村武司, 田中榮司
医学のあゆみ, 262(14), 1336-1340, 2017年09月

Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis
Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M
Liver Int, 37(6), 897-905, 2017年06月

Successful Treatment for Chronic Hepatitis C-Autoimmune Hepatitis Overlap Syndrome due to Daclatasvir and Asunaprevir
Sugiura A, Wada S, Mori H, Kimura T, Matsuda Y, Tanaka N, Tanaka E, Kiyosawa K
Case Rep Gastroenterol, 11(2), 305-311, 2017年05月

Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody
Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E
J Gastroenterol, 52(3), 376-384, 2017年05月

【混合型肝癌をめぐる混乱の終焉を目指して】 混合型肝癌[ICD-0 code 8180/3(WHO2010)]の画像診断
上田和彦, 平塚真生子, 松枝清, 高澤豊, 笹平直樹, 齋浦明夫, 田中榮司, 宮川眞一
肝・胆・膵, 74(5), 761-767, 2017年05月

6年間に40回以上の内視鏡的バルーン拡張術を要した食道慢性GVHDの1例
平山敦大, 菅智明, 大野和幸, 小林惇一, 齊藤博美, 日原 優, 横田有紀子, 伊東哲宏, 中村麗那, 北畠央之, 田中景子, 岡村卓磨, 田中榮司
ENDOSCOPIC FORUM for digestive disease, 33(1), 51, 2017年05月

Association of Serum Autotaxin Levels with Liver Fibrosis in Patients with Chronic Hepatitis C
Yamazaki T, Joshita S, Umemura T, Usami Y, Sugiura A, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Igarashi K, Tanaka E
Sci Rep, 7, 46705, 2017年04月

Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection
Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E
Hepatol Res, 47(5), 405-418, 2017年04月

関節リウマチ治療中に発症した悪性リンパ腫の1例
酒井均, 川上徹, 須藤祐里子, 仁科さやか, 妹尾紀子, 中澤英之, 田中榮司
長野県医学会雑誌, 47, 101, 2017年03月

IgG4関連疾患における悪性腫瘍発症
浅野純平, 渡邉貴之, 北野真希子, 中村晃, 伊藤哲也, 田中榮司
長野県医学会雑誌, 47, 26-27, 2017年03月

【内科領域におけるウイルス感染症〜ウイルス感染症に対する最新の知識と治療〜】 日常遭遇することの多いウイルス感染症　肝炎領域　B型肝炎
田中榮司
日本内科学会雑誌, 106(3), 422-427, 2017年03月

Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up
Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, Suga T, Nakamura Y, Akamatsu T, Tanaka E
Clin J Gastroenterol, 10(1), 79-85, 2017年02月

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection
Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E
Hepatol Res, 47(2), 226-233, 2017年02月

Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis
Yamazaki T, Ochi Y, Tanaka N, Watanabe T, Iwaya Y, Seki A, Hara E, Tanaka E, Watanabe T, Imai S, Hasebe O
Clin J Gastroenterol, 10(1), 73-78, 2017年02月

Association between endotoxemia and histological features of nonalcoholic fatty liver disease
Kitabatake H, Tanaka N, Fujimori N, Komatsu M, Okubo A, Kakegawa K, Kimura T, Sugiura A, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Koinuma M, Sano K, Aoyama T, Tanaka E
World J Gastroenterol, 23(4), 712-722, 2017年01月

The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study
Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O
J Gastroenterol, 52(1), 113-122, 2017年01月

【エキスパートが教える薬の使い方×エビデンスの調べ方】 (第1章)よくある疾患に対する薬の使い分け　肝炎
梅村武司, 田中榮司
薬事, 59(2), 280-284, 2017年01月

The prognosis of hepatitis B inactive carriers in Japan: a multicenter prospective study.
Taida T, Arai M, Kanda T, Hige S, Ueno Y, Imazeki F, Izumi N, Tanaka E, Shinkai N, Yoshioka K, Nakamoto Y, Nishiguchi S, Tsuge M, Abe M, Sata M, Yatsuhashi H, Ido A, Kita K, Azemoto R, Kitsukawa Y, Goto N, Yokosuka O
J Gastroenterol, 52(1), 113-122, 2017年01月

Genetic Contribution to the Pathogenesis of Primary Biliary Cholangitis
Joshita S, Umemura T, Tanaka E, Ota M
J Immunol Res, 3073504, 2017年

Survival in patients with Child-Pugh class C cirrhosis: analysis of the liver transplant registry in Japan.
Genda T, Ichida T, Sakisaka S, Tanaka E, Mochida S, Ueno Y, Inui A, Egawa H, Umeshita K, Furukawa H, Kawasaki S, Inomata Y
Hepatol Res, in press, 2016年12月

Massive ascites caused by intra-pancreatic arterioportal fistula: a rare complication of chronic pancreatitis.
Yamazaki T, Ochi Y, Tanaka N, Watanabe T, Iwaya Y, Seki A, Hara E, Tanaka E, Watanabe T, Imai S, Hasebe O
Clin J Gastroenterol, in press, 2016年12月

Development of diffuse large B-cell lymphoma from follicular lymphoma of the duodenum: changes in endoscopic findings during a 6-year follow-up.
Kitabatake H, Nagaya T, Tanaka N, Ota H, Sano K, Asano N, Suga T, Nakamura Y, Akamatsu T, Tanaka E
Clin J Gastroenterol, in press, 2016年11月

Association between serum soluble CD14 and IL-8 levels and clinical outcome in primary biliary cholangitis.
Umemura T, Sekiguchi T, Joshita S, Yamazaki T, Fujimori N, Shibata S, Ichikawa Y, Komatsu M, Matsumoto A, Shums Z, Norman GL, Tanaka E, Ota M
Liver Int, in press, 2016年11月

Liver transplantation in Japan: Registry by the Japanese Liver Transplantation Society.
Umeshita K, Inomata Y, Furukawa H, Kasahara M, Kawasaki S, Kobayashi E, Kokudo N, Sakisaka S, Shimada M, Tanaka E, Uemoto S; Japanese Liver Transplantation Society.
Hepatol Res, 46(12), 1171-1186, 2016年11月

Induction of IFN-λ3 as an additional effect of nucleotide, not nucleoside, analogues: a new potential target for HBV infection.
Murata K, Asano M, Matsumoto A, Sugiyama M, Nishida N, Tanaka E, Inoue T, Sakamoto M, Enomoto N, Shirasaki T, Honda M, Kaneko S, Gatanaga H, Oka S, Kawamura YI, Dohi T, Shuno Y, Yano H, Mizokami M
Gut, in press, 2016年10月

Production of infectious HCV genotype 1b virus in cell culture using a novel Set of adaptive mutations.
Mori KI, Matsumoto A, Maki N, Ichikawa Y, Tanaka E, Yagi S
BMC Microbiol, 16(1), 224, 2016年09月

Controlled attenuation parameter is correlated with actual hepatic fat content in patients with non-alcoholic fatty liver disease with none-to-mild obesity and liver fibrosis.
Fujimori N, Tanaka N, Shibata S, Sano K, Yamazaki T, Sekiguchi T, Kitabatake H, Ichikawa Y, Kimura T, Komatsu M, Umemura T, Matsumoto A, Tanaka E
Hepatol Res, 46(10), 1019-27, 2016年09月

A case of simultaneous esophageal squamous cell carcinoma and Barrett's adenocarcinoma.
Yamazaki T, Iwaya Y, Iwaya M, Watanabe T, Seki A, Ochi Y, Hara E, Sekiguchi T, Hosaka N, Arakura N, Tanaka E, Hasebe O
Clin J Gastroenterol, 9(4), 222-7, 2016年08月

Incidence and prevalence of autoimmune hepatitis in the Ueda area, Japan.
Yoshizawa K, Joshita S, Matsumoto A, Umemura T, Tanaka E, Morita S, Maejima T, Ota M
Hepatol Res, 46(9), 878-83, 2016年08月

Liver stiffness-spleen size-to-platelet ratio risk score identifies esophageal varices in Japanese patients with chronic hepatitis C.
Shibata S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E
Hepatol Res, 46(9), 884-9, 2016年08月

Novel and highly sensitive immunoassay for total hepatitis B surface antigen, including that complexed with hepatitis B surface antibody.
Matsumoto A, Imaizumi M, Tanaka Y, Nishiguchi S, Yatsuhashi H, Ishida T, Moriyama K, Aoyagi K, Tanaka E
J Gastroenterol, in press, 2016年07月

Genetic Association of PTPN22 Polymorphisms with Autoimmune Hepatitis and Primary Biliary Cholangitis in Japan.
Umemura T, Joshita S, Yamazaki T, Komatsu M, Katsuyama Y, Yoshizawa K, Tanaka E, Ota M
Sci Rep, 6, 29770, 2016年07月

Liver stiffness-spleen size-to-platelet ratio risk score detects esophageal varices in chronic liver disease.
Shibata S, Joshita S, Umemura T, Yamazaki T, Fujimori N, Ichikawa Y, Komatsu M, Matsumoto A, Tanaka E
Springerplus, 5(1), 998, 2016年07月

Case of Barrett's adenocarcinoma with marked endoscopic morphological changes in Barrett's esophagus over a long follow-up period of 15 years.
Iwaya Y, Yamazaki T, Watanabe T, Seki A, Ochi Y, Hara E, Arakura N, Tanaka E, Hasebe O
Dig Endosc, 28(5), 607-10, 2016年07月

Clinicopathological characteristics of non-B non-C hepatocellular carcinoma without past hepatitis B virus infection.
Kimura T, Kobayashi A, Tanaka N, Sano K, Komatsu M, Fujimori N, Yamazaki T, Shibata S, Ichikawa Y, Joshita S, Umemura T, Matsumoto A, Horiuchi A, Mori H, Wada S, Kiyosawa K, Miyagawa SI, Tanaka E
Hepatol Res, in press, 2016年06月

Severe hepatotoxicity associated with asunaprevir and daclatasvir in chronic hepatitis C.
Shibata S, Umemura T, Komatsu M, Tanaka E
Hepatology, 63(6), 2063-4, 2016年06月

A Case of Esophageal Hemangioma Successfully Treated by Endoscopic Injection Sclerotherapy
Suga Tomoaki, Okamura Takuma, Iwaya Yugo, Ito Tetsuya, Arakura Norikazu, Umemura Takeji, Tanaka Eiji
信州医学雑誌, 64(2), 75-78, 2016年04月10日

Understanding of HLA-conferred susceptibility to chronic hepatitis B infection requires HLA genotyping-based association analysis.
Nishida N, Ohashi J, Khor SS, Sugiyama M, Tsuchiura T, Sawai H, Hino K, Honda M, Kaneko S, Yatsuhashi H, Yokosuka O, Koike K, Kurosaki M, Izumi N, Korenaga M, Kang JH, Tanaka E, Taketomi A, Eguchi Y, Sakamoto N, Yamamoto K, Tamori A, et al
Sci Rep, 6, 24767, 2016年04月

Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein may predict liver fibrosis and progression to hepatocellular carcinoma in patients with chronic hepatitis B virus infection.
Ichikawa Y, Joshita S, Umemura T, Shobugawa Y, Usami Y, Shibata S, Yamazaki T, Fujimori N, Komatsu M, Matsumoto A, Tanaka E
Hepatol Res, in press, 2016年03月

The loop-forming method as a useful technique to rotate the endoscopic insertion tube shaft.
Suga T, Okamura T, Arakura N, Tanaka E
Endosc Int Open, 4(2), E170-4, 2016年02月

JSH Guidelines for the Management of Hepatitis C Virus Infection: A 2016 update for genotype 1 and 2.
Asahina Y, Izumi N, Hiromitsu K, Kurosaki M, Koike K, Suzuki F, Takikawa H, Tanaka A, Tanaka E, Tanaka Y, Tsubouchi H, Hayashi N, Hiramatsu N, Yotsuyanagi H
Hepatol Res, 46(2), 129-65, 2016年02月

Lymphocyte Antigen 75 Polymorphisms Are Associated with Disease Susceptibility and Phenotype in Japanese Patients with Inflammatory Bowel Disease.
Hirayama A, Joshita S, Kitahara K, Mukawa K, Suga T, Umemura T, Tanaka E, Ota M
Dis Markers, 2016, 6485343, 2016年

Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine.
Daikuhara S, Uehara T, Higuchi K, Hosaka N, Iwaya M, Maruyama Y, Matsuda K, Arakura N, Tanaka E, Ota H
Acta Histochem Cytochem, 48(6), 193-204, 2015年12月

Factors associated with the effect of interferon-α sequential therapy in order to discontinue nucleoside/nucleotide analog treatment in patients with chronic hepatitis B.
Matsumoto A, Yatsuhashi H, Nagaoka S, Suzuki Y, Hosaka T, Tsuge M, Chayama K, Kanda T, Yokosuka O, Nishiguchi S, Saito M, Miyase S, Kang JH, Shinkai N, Tanaka Y, Umemura T, Tanaka E
Hepatol Res, 45(12), 1195-202, 2015年12月

A case of MUC5AC-positive intraductal neoplasm of the pancreas classified as an intraductal tubulopapillary neoplasm?
Muraki T, Uehara T, Sano K, Oota H, Yoshizawa A, Asaka S, Tateishi A, Otsuki T, Shingu K, Matoba H, Kobayashi S, Ichimata S, Watanabe T, Itou T, Tanaka E
Pathol Res Pract, 211(12), 1034-9, 2015年12月

Clinicopathological characterisation of duodenal adenocarcinoma with high CD44 variant 9 expression.
Maruyama Y, Uehara T, Daikuhara S, Kobayashi Y, Nakajima T, Matsumoto A, Tanaka E, Ota H
PATHOLOGY, 47(7), 647-52, 2015年12月

A case of acquired hemophilia A diagnosed after percutaneous endoscopic gastrostomy.
Okamura T, Komatsu M, Ito A, Ito T, Suga T, Arakura N, Sakai H, Tanaka E
Clin J Gastroenterol, 8(5), 290-3, 2015年10月

Reduced gland mucin-specific O-glycan in gastric atrophy: A possible risk factor for differentiated-type adenocarcinoma of the stomach.
Yamada S, Okamura T, Kobayashi S, Tanaka E, Nakayama J
J Gastroenterol Hepatol, 30(10), 1478-84, 2015年10月

Monitoring of Hepatitis B Virus (HBV) DNA and Risk of HBV Reactivation in B-Cell Lymphoma: A Prospective Observational Study.
Kusumoto S, Tanaka Y, Suzuki R, Watanabe T, Nakata M, Takasaki H, Fukushima N, Fukushima T, Moriuchi Y, Itoh K, Nosaka K, Choi I, Sawa M, Okamoto R, Tsujimura H, Uchida T, Suzuki S, Okamoto M, Takahashi T, Sugiura I, Onishi Y, Kohri M, et al
Clin Infect Dis, 61(5), 719-29, 2015年09月

Primary hepatocellular carcinoma in a patient with neurofibromatosis type I.
Kimura T, Tanaka N, Umemura T, Tanaka E
Liver Int, 35(8), 2057-8, 2015年08月

Serum sodium concentration is associated with increased risk of mortality in patients with compensated liver cirrhosis.
Umemura T, Shibata S, Sekiguchi T, Kitabatake H, Nozawa Y, Okuhara S, Kimura T, Morita S, Komatsu M, Matsumoto A, Tanaka E
Hepatol Res, 45(7), 739-44, 2015年07月

Serum cell death biomarkers for prediction of liver fibrosis and poor prognosis in primary biliary cirrhosis.
Sekiguchi T, Umemura T, Fujimori N, Shibata S, Ichikawa Y, Kimura T, Joshita S, Komatsu M, Matsumoto A, Tanaka E, Ota M
PLOS ONE, 10(6), e0131658, 2015年06月

Serum Wisteria floribunda Agglutinin-Positive Mac-2-Binding Protein Level Predicts Liver Fibrosis and Prognosis in Primary Biliary Cirrhosis.
Umemura T, Joshita S, Sekiguchi T, Usami Y, Shibata S, Kimura T, Komatsu M, Matsumoto A, Ota M, Tanaka E
Am J Gastroenterol, 110(6), 857-64, 2015年06月

Steatogenesis in adult-onset type II citrullinemia is associated with down-regulation of PPARα.
Komatsu M, Kimura T, Yazaki M, Tanaka N, Yang Y, Nakajima T, Horiuchi A, Fang ZZ, Joshita S, Matsumoto A, Umemura T, Tanaka E, Gonzalez FJ, Ikeda S, Aoyama T
Biochim Biophys Acta, 1852(3), 473-81, 2015年03月

Mechanism of the development of nonalcoholic steatohepatitis after pancreaticoduodenectomy.
Nagaya T, Tanaka N, Kimura T, Kitabatake H, Fujimori N, Komatsu M, Horiuchi A, Yamaura T, Umemura T, Sano K, Gonzalez FJ, Aoyama T, Tanaka E
BBA Clin, 3, 168-74, 2015年02月

Mutations of pre-core and basal core promoter before and after hepatitis B e antigen seroconversion.
Kamijo N, Matsumoto A, Umemura T, Shibata S, Ichikawa Y, Kimura T, Komatsu M, Tanaka E
World J Gastroenterol, 21(2), 541-8, 2015年01月

Superficially located enlarged lymphoid follicles characterise nodular gastritis.
Okamura T, Sakai Y, Hoshino H, Iwaya Y, Tanaka E, Kobayashi M
PATHOLOGY, 47(1), 38-44, 2015年01月

Human Leukocyte Antigen Class II Haplotypes Affect Clinical Characteristics and Progression of Type 1 Autoimmune Hepatitis in Japan
Umemura, T; Katsuyama, Y; Yoshizawa, K; Kimura, T; Joshita, S; Komatsu, M; Matsumoto, A; Tanaka, E; Ota, M
PLOS ONE, 9(6), e100565, 2014年06月

Guidelines for avoiding risks resulting from discontinuation of nucleoside/nucleotide analogs in patients with chronic hepatitis B
Tanaka, E; Matsumoto, A
Hepatol Res, 44(1), 1-8, 2014年01月

STAT4 Gene Polymorphisms Are Associated with Susceptibility and ANA Status in Primary Biliary Cirrhosis
Joshita, S; Umemura, T; Nakamura, M; Katsuyama, Y; Shibata, S; Kimura, T; Morita, S; Komatsu, M; Matsumoto, A; Yoshizawa, K; Ishibashi, H; Tanaka, E; Ota, M
DISEASE MARKERS, 2014, 727393, 2014年

Cutaneous sarcoidosis in a chronic hepatitis C patient receiving pegylated interferon and ribavirin therapy
Joshita, S; Shirahata, K; Yazaki, Y; Okaniwa, S; Nakamura, Y; Kimura, T; Noami, S; Horigome, R; Yagi, H; Ito, N; Yamazaki, A; Akahane, Y; Umemura, T; Yoshizawa, K; Tanaka, E; Ota, M
HEPATOLOGY RESEARCH, 43(7), 801-807, 2013年07月

Comparison of carbon dioxide and air insufflation use by non-expert endoscopists during endoscopic retrograde cholangiopancreatography
Muraki, T; Arakura, N; Kodama, R; Yoneda, S; Maruyama, M; Itou, T; Watanabe, T; Maruyama, M; Matsumoto, A; Kawa, S; Tanaka, E
DIGESTIVE ENDOSCOPY, 25(2), 189-196, 2013年03月

Association analysis of toll-like receptor 4 polymorphisms in Japanese primary biliary cirrhosis
Morita, S; Joshita, S; Umemura, T; Katsuyama, Y; Kimura, T; Komatsu, M; Matsumoto, A; Yoshizawa, K; Kamijo, A; Yamamura, N; Tanaka, E; Ota, M
HUMAN IMMUNOLOGY, 74(2), 219-222, 2013年02月

Liver Dysfunction and Thrombocytopenia Diagnosed as Intravascular Large B-cell Lymphoma Using a Timely and Accurate Transjugular Liver Biopsy
Sekiguchi, N; Joshita, S; Yoshida, T; Kurozumi, M; Sano, K; Nakagawa, M; Ito, T; Matsushita, T; Komatsu, D; Komatsu, M; Ito, T; Umemura, T; Ikeda, S; Kadoya, M; Ishida, F; Tanaka, E
INTERNAL MEDICINE, 52(17), 1903-1908, 2013年

Changes in the serum level of hepatitis B virus (HBV) surface antigen over the natural course of HBV infection
Matsumoto A, Tanaka E, Morita S, Yoshizawa K, Umemura T, Joshita S
J Gastroenterol, 47(9), 1006-1013, 2012年09月

2011 Japanese society for dialysis therapy guidelines for the treatment of hepatitis C virus infection in dialysis patients
Akiba T, Hora K, Imawari M, Sato C, Tanaka E, Izumi N, Harada T, Ando R, Kikuchi K, Tomo T, Hirakata H, Akizawa T
Ther Apher Dia, 16(4), 289-310, 2012年08月

Helicobacter pylori-Negative Primary Rectal MALT Lymphoma: Complete Remission after Radiotherapy
Okamura T, Suga T, Iwaya Y, Ito T, Yokosawa S, Arakura N, Ota H, Tanaka E
Case Rep Gastroenterol, 6(2), 319-27, 2012年07月

No association for Chinese HBV-related hepatocellular carcinoma susceptibility SNP in other East Asian populations
Sawai H, Nishida N, Mbarek H, Matsuda K, Mawatari Y, Yamaoka M, Hige S, Kang J. H, Abe K, Mochida S, Watanabe M, Kurosaki M, Asahina Y, Izumi N, Honda M, Kaneko S, Tanaka E, Matsuura K, Itoh Y, Mita E, Korenaga M, Hino K, Murawaki Y, Hiasa Y, Ide T, Ito K, Sugiyama M, Ahn S. H, Han K. H, Park J. Y, Yuen M. F, Nakamura Y, Tanaka Y, Mizokami M, Tokunaga K
BMC Med Genet, 13, 47, 2012年06月

Genome-wide association study confirming association of HLA-DP with protection against chronic hepatitis B and viral clearance in Japanese and Korean
Nishida N, Sawai H, Matsuura K, Sugiyama M, Ahn S. H, Park J. Y, Hige S, Kang J. H, Suzuki K, Kurosaki M, Asahina Y, Mochida S, Watanabe M, Tanaka E, Honda M, Kaneko S, Orito E, Itoh Y, Mita E, Tamori A, Murawaki Y, Hiasa Y, Sakaida I, Korenaga M, Hino K, Ide T, Kawashima M, Mawatari Y, Sageshima M, Ogasawara Y, Koike A, Izumi N, Han KH, Tanaka Y, Tokunaga K, Mizokami M
PLOS ONE, 7(6), e39175, 2012年06月

Hepatic Cerebroside Sulfotransferase Is Induced by PPARalpha Activation in Mice
Kimura T, Nakajima T, Kamijo Y, Tanaka N, Wang L, Hara A, Sugiyama E, Tanaka E, Gonzalez Frank J, Aoyama T
PPAR Res, 174932, 2012年05月

Risk of hepatitis B reactivation in patients treated with tumor necrosis factor-alpha inhibitors
Tanaka E, Urata Y
Hepatol Res, 42(4), 333-339, 2012年04月

Association of IL28B gene polymorphism with development of hepatocellular carcinoma in Japanese patients with chronic hepatitis C virus infection
Joshita, Satoru; Umemura, Takeji; Katsuyama, Yoshihiko; Ichikawa, Yuki; Kimura, Takefumi; Morita, Susumu; Kamijo, Atsushi; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Kamijo, Nozomi; Ota, Masao; Tanaka, Eiji
HUMAN IMMUNOLOGY, 73(3), 298-300, 2012年03月

Combination of hepatitis B viral antigens and DNA for prediction of relapse after discontinuation of nucleos(t)ide analogs in patients with chronic hepatitis B
Matsumoto A, Tanaka E, Suzuki Y, Kobayashi M, Tanaka Y, Shinkai N, Hige S, Yatsuhashi H, Nagaoka S, Chayama K, Tsuge M, Yokosuka O, Imazeki F, Nishiguchi S, Saito M, Fujiwara K, Torii N, Hiramatsu N, Karino Y, Kumada H
Hepatol Res, 42(2), 139-149, 2012年02月

Long-term outcome of japanese patients with type 1 autoimmune hepatitis
Yoshizawa K, Matsumoto A, Ichijo T, Umemura T, Joshita S, Komatsu M, Tanaka N, Tanaka E, Ota M, Katsuyama Y, Kiyosawa K, Abe M, Onji M
56(2), 668-676, 2012年02月

Human leukocyte antigen class II molecules confer both susceptibility and progression in Japanese patients with primary biliary cirrhosis
Umemura T, Joshita S, Ichijo T, Yoshizawa K, Katsuyama Y, Tanaka E
Hepatology, 55(2), 506-511, 2012年02月

Assessment of safety of using antithrombotic agents during esophagogastroduodenoscopy: rationale and design of the ASAMA Study
Kasai H, Suga T, Ikeda U, Yoshioka J, Tanaka E, Akamatsu T, for the ASAMA study Investigators
Shinshu Medical Journal, 60(3), 143-148, 2012年

Introduction of an examination and treatment for Helicobacter pylori infection in high school health screening.
Akamatsu T, Ichikawa S, Okudaira S, Yokosawa S, Iwaya Y, Suga T, Ota H, Tanaka E
J Gastroenterol, 46(12), 1353-1360, 2011年12月

Genetic polymorphisms in CTLA4 and SLC4A2 are differentially associated with the pathogenesis of primary biliary cirrhosis in Japanese patients
Aiba Y, Nakamura M, Joshita S, Inamine T, Komori A, Yoshizawa K, Umemura T, Horie H, Migita K, Yatsuhashi H, Nakamuta M, Fukushima N, Saoshiro T, Hayashi S, Kouno H, Ota H, Muro T, Watanabe Y, Nakamura Y, Komeda T, Shimada M, Masaki N, Komatsu T, Yagura M, Sugi K, Koga M, Tsukamoto K, Tanaka E, Ishibashi H, P. B. C. Study Group in NHOSLJ
J Gastroenterol, 46(10), 1203-1212, 2011年10月

Serum interleukin (IL)-10 and IL-12 levels and IL28B gene polymorphisms: pretreatment prediction of treatment failure in chronic hepatitis C.
Umemura T, Joshita S, Yoneda S, Katsuyama Y, Ichijo T, Matsumoto A, Yoshizawa K, Ota M, Tanaka E
Antivir Ther, 16(7), 1073-1080, 2011年10月

Primary gastric diffuse large B-cell lymphoma with orbital involvement: diagnostic usefulness of 18F-fluorodeoxyglucose positron emission tomography.
Iwaya Y, Takenaka K, Akamatsu T, Yamada Y, Haba S, Matsuda K, Nakazawa H, Muraki T, Kaneko Y, Ito T, Sano K, Arakura N, Tanaka E, Ishida F
Intern Med, 50(18), 1953-1956, 2011年09月

Genome-wide association study identified ITPA/DDRGK1 variants reflecting thrombocytopenia in pegylated interferon and ribavirin therapy for chronic hepatitis C
Tanaka Y, Kurosaki M, Nishida N, Sugiyama M, Matsuura K, Sakamoto N, Enomoto N, Yatsuhashi H, Nishiguchi S, Hino K, Hige S, Itoh Y, Tanaka E, Mochida S, Honda M, Hiasa Y, Koike A, Sugauchi F, Kaneko S, Izumi N, Tokunaga K, Mizokami M
HUMAN MOLECULAR GENETICS, 20(17), 3507-3516, 2011年09月

Early detection of interstitial pneumonia by monitoring KL-6 in a chronic hepatitis C patient undergoing pegylated interferon and ribavirin therapy
Ichikawa-Yamada Y, Joshita S, Tsukahara Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E
HEPATOLOGY RESEARCH, 41(9), 904-909, 2011年09月

Clinical characteristics of de novo nonalcoholic fatty liver disease following pancreaticoduodenectomy
Tanaka N, Horiuchi A, Yokoyama T, Kaneko G, Horigome N, Yamaura T, Nagaya T, Komatsu M, Sano K, Miyagawa S, Aoyama T, Tanaka E
JOURNAL OF GASTROENTEROLOGY, 46(6), 758-768, 2011年06月

Serum chemokine levels are associated with the outcome of pegylated interferon and ribavirin therapy in patients with chronic hepatitis C
Yoneda S, Umemura T, Joshita S, Ichijo T,Matsumoto A, Yoshizawa K, Katsuyama Y, Ota M, Tanaka E
HEPATOLOGY RESEARCH, 41(6), 587-593, 2011年06月

Association of IL28B variants with response to pegylated-interferon alpha plus ribavirin combination therapy reveals intersubgenotypic differences between genotypes 2a and 2b
Sakamoto N, Nakagawa M, Tanaka Y, Sekine-Osajima Y, Ueyama M, Kurosaki M, Nishida N, Tamori A, Yuki NS, Itsui Y, Azuma S, Kakinuma S, Hige S, Itoh Y, Tanaka E, Hiasa Y, Izumi N, Tokunaga K, Mizokami M, Watanabe M
JOURNAL OF MEDICAL VIROLOGY, 83(5), 871-878, 2011年05月

Cytokine profiles affecting the pathogenesis of autoimmune hepatitis in Japanese patients
Kamijo A, Yoshizawa K, Joshita S, Yoneda S, Umemura T, Ichijo T, Matsumoto A, Ota M, Tanaka E
HEPATOLOGY RESEARCH, 41(4), 350-357, 2011年04月

Association of Serum Cytokine Levels With Treatment Response to Pegylated Interferon and Ribavirin Therapy in Genotype 1 Chronic Hepatitis C Patients
Yoneda, Suguru; Umemura, Takeji; Katsuyama, Yoshihiko; Kamijo, Atsushi; Joshita, Satoru; Komatsu, Michiharu; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Ota, Masao; Tanaka, Eiji
JOURNAL OF INFECTIOUS DISEASES, 203(8), 1087-1095, 2011年04月

Management of hepatitis B: Consensus of the Japan Society of Hepatology 2009
Yokosuka O, Kurosaki M, Imazeki F, Arase Y, Tanaka Y, Chayama K, Tanaka E, Kumada H, Izumi N, Mizokami M, Kudo M
HEPATOLOGY RESEARCH, 41(1), 1-21, 2011年01月

Clinical significance of immunoglobulin G4-associated autoimmune hepatitis
Umemura T, Zen Y, Hamano H, Joshita S, Ichijo T, Yoshizawa K, Kiyosawa K, Ota M, Kawa S, Nakanuma Y, Tanaka E
JOURNAL OF GASTROENTEROLOGY, 46(SUPPL 1), 48-55, 2011年01月

A Case of Pyogenic Liver Abscess Infected with Fusobacterium necrophorum Depicted by Microscopy and Confirmed by Tissue Culture
Nozawa Y, Joshita S, Fukushima M, Sugiyama Y, Ichikawa Y, Kimura T, Morita S, Kamijo A, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Tanaka E
INTERNAL MEDICINE, 50(17), 1815-1819, 2011年

Severe hepatic encephalopathy and decrease in enhancement of hepatocellular carcinoma treated with sorafenib
Kimura T, Umemura T, Ichijo T, Yamamura N, Tanaka E
International Journal of Case Reports and Images, 1(4), 16-18, 2010年12月

Accurate and simple method for quantification of hepatic fat content using magnetic resonance imaging: a prospective study in biopsy-proven nonalcoholic fatty liver disease
Hatta T, Fujinaga Y, Kadoya M, Ueda H, Murayama H, Kurozumi M, Ueda K, Komatsu M, Nagaya T, Joshita S, Kodama R, Tanaka E, Uehara T, Sano K, Tanaka N
JOURNAL OF GASTROENTEROLOGY, 45(12), 1263-1271, 2010年12月

Small bowel tissue concentration of rebamipide: study of two dosages in healthy subjects
Akamatsu T, Nagaya T, Ichikawa S, Sudo T, Takeda R, Takenaka K, Kodama R, Ito T, Arakura N, Tanaka E
Journal of Clinical Biochemistry and Nutrition, 47(3), 256-260, 2010年11月

Eicosapentaenoic acid improves hepatic steatosis independent of PPARalpha activation through inhibition of SREBP-1 maturation in mice
Tanaka N, Zhang X, Sugiyama E, Kono H, Horiuchi A, Nakajima T, Kanbe H, Tanaka E, Gonzalez FJ, Aoyama T
Biochemical Pharmacology, 80(10), 1601-1612, 2010年11月

Down-regulation of SREBP-1c is associated with the development of burned-out NASH
Nagaya T, Tanaka N, Suzuki T, Sano K, Horiuchi A, Komatsu M, Nakajima T, Nishizawa T, Joshita S, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Nakayama J, Tanaka E, Aoyama T
JOURNAL OF HEPATOLOGY, 53(4), 724-731, 2010年10月

Chronic gastritis in the setting of autoimmune pancreatitis
Uehara T, Hamano H, Kawa S, Sano K, Oki K, Kobayashi Y, Nagaya T, Akamatsu T, Kurozumi M, Fujinaga Y, Tanaka E, Honda T, Ota H
AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 34(9), 1241-1249, 2010年09月

Association analysis of cytotoxic T-lymphocyte antigen 4 gene polymorphisms with primary biliary cirrhosis in Japanese patients
Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Nakamura, Minoru; Ishibashi, Hiromi; Ota, Masao
JOURNAL OF HEPATOLOGY, 53(3), 537-541, 2010年09月

Fucosylated fraction of alpha-fetoprotein as a predictor of prognosis in patients with hepatocellular carcinoma after curative treatment
Tamura Y, Igarashi M, Suda T, Wakai T, Shirai Y, Umemura T, Tanaka E, Kakizaki S, Takagi H, Hiasa Y, Onji M, Aoyagi Y
DIGESTIVE DISEASES AND SCIENCES, 55(7), 2095-2101, 2010年07月

Effect of bezafibrate on hepatic oxidative stress: comparison between conventional experimental doses and clinically-relevant doses in mice.
Nakajima T, Tanaka N, Li G, Hu R, Kamijo Y, Hara A, Aoyama T
Redox Rep, 15(3), 123-130, 2010年07月

Serum Fragmented Cytokeratin 18 Levels Reflect the Histologic Activity Score of Nonalcoholic Fatty Liver Disease More Accurately Than Serum Alanine Aminotransferase Levels
Tsutsui, Masaru; Tanaka, Naoki; Kawakubo, Masatomo; Sheena, Yo; Horiuchi, Akira; Komatsu, Michiharu; Nagaya, Tadanobu; Joshita, Satoru; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji; Sano, Kenji
JOURNAL OF CLINICAL GASTROENTEROLOGY, 44(6), 440-447, 2010年07月

Nonalcoholic fatty liver disease in Japanese junior high school students: its prevalence and relationship to lifestyle habits
Tsuruta, Goro; Tanaka, Naoki; Hongo, Minoru; Komatsu, Michiharu; Horiuchi, Akira; Hamamoto, Kaeko; Iguchi, Chieko; Nakayama, Yoshiko; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Yoshizawa, Kaname; Aoyama, Toshifumi; Tanaka, Eiji
JOURNAL OF GASTROENTEROLOGY, 45(6), 666-672, 2010年06月

A2BP1 as a novel susceptible gene for primary biliary cirrhosis in Japanese patients
Joshita, Satoru; Umemura, Takeji; Yoshizawa, Kaname; Katsuyama, Yoshihiko; Tanaka, Eiji; Ota, Masao
HUMAN IMMUNOLOGY, 71(5), 520-524, 2010年05月

A Case of Granulocyte-Colony Stimulating Factor-Producing Hepatocellular Carcinoma Confirmed by Immunohistochemistry
Joshita, Satoru; Nakazawa, Koh; Koike, Shoichiro; Kamijo, Atsushi; Matsubayashi, Kiyoshi; Miyabayashi, Hideharu; Furuta, Kiyoshi; Kitano, Kiyoshi; Yoshizawa, Kaname; Tanaka, Eiji
JOURNAL OF KOREAN MEDICAL SCIENCE, 25(3), 476-480, 2010年03月

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis C virus infection for the fiscal year 2008 in Japan
Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y
HEPATOLOGY RESEARCH, 40(1), 8-13, 2010年01月

Guidelines for the treatment of chronic hepatitis and cirrhosis due to hepatitis B virus infection for the fiscal year 2008 in Japan
Kumada H, Okanoue T, Onji M, Moriwaki H, Izumi N, Tanaka E, Chayama K, Sakisaka S, Takehara T, Oketani M, Suzuki F, Toyota J, Nomura H, Yoshioka K, Seike M, Yotsuyanagi H, Ueno Y
HEPATOLOGY RESEARCH, 40(1), 1-7, 2010年01月

Usefulness of double balloon enteroscopy and video capsule endoscopy for the diagnosis and management of primary follicular lymphoma of the gastrointestinal tract in its early stages
Akamatsu T, Kaneko Y, Ota H, Miyabayashi H, Arakura N, Tanaka E
DIGESTIVE ENDOSCOPY, 22(1), 33-38, 2010年01月

A Patient with Advanced Hepatocellular Carcinoma Treated with Sorafenib Tosylate Showed Massive Tumor Lysis with Avoidance of Tumor Lysis syndrome
Joshita, Satoru; Yoshizawa, Kaname; Sano, Kenji; Kobayashi, Satoshi; Sekiguchi, Tomohiro; Morita, Susumu; Kamijo, Atsushi;Komatsu, Michiharu; Umemura, Takeji; Ichijo, Tetsuya; Matsumoto, Akihiro; Tanaka, Eiji
INTERNAL MEDICINE, 49(11), 991-994, 2010年

CLINICAL AND VIROLOGICAL FEATURES OF PATIENTS WITH FULMINANT HEPATIC FAILURE DUE TO HEPATITIS B VIRUS REACTIVATION FROM HBSAG-NEGATIVE STATUS
Umemura, T.; Kiyosawa, K.; Tanaka, E.; Grp, Japan Novo Hepatitis B. Res
JOURNAL OF HEPATOLOGY, 52(Suppl. 1), S286-S286, 2010年

Down-regulation of SREBP-1c is associated with the development of burned-out NASH
Nagaya, T.; Tanaka, N.; Komatsu, M.; Joshita, S.; Umemura, T.; Ichijo, T.; Matsumoto, A.; Yoshizawa, K.; Aoyama, T.; Tanaka, E.
JOURNAL OF HEPATOLOGY, 52(Suppl. 1), S373-S374, 2010年

Comparison of hepatitis B virus DNA, RNA, and core related antigen as predictors of lamivudine resistance in patients with chronic hepatitis B
Matsumoto A, Maki N, Yoshizawa K, Umemura T, Joshita S, Tanaka E
ShinshuMed J, 58(4), 153-162, 2010年

Combination Chemotherapy with Low-dose 5-FU, Cisplatin, and Gemcitabine for Gemcitabine-Refractory Pancreatic Cancer
Norikazu ARAKURA, Osamu HASEBE, Yasuhide OCHI, Hideaki HAMANO, Eiji TANAKA, Shigeyuki KAWA
信州医学雑誌, 57(6), 247-253, 2009年12月

Predictive values of amino acid sequences of the core and NS5A regions in antiviral therapy for hepatitis C: a Japanese multi-center study
Okanoue, Takeshi; Itoh, Yoshito; Hashimoto, Hiroaki; Yasui, Kohichiroh; Minami, Masahito; Takehara, Tetsuo; Tanaka, Eiji; Onji, Morikazu; Toyota, Joji; Chayama, Kazuaki; Yoshioka, Kentaro; Izumi, Namiki; Akuta, Norio; Kumada, Hiromitsu
JOURNAL OF GASTROENTEROLOGY, 44(9), 952-963, 2009年09月

A case of well-differentiated cholangiolocellular carcinoma visualizedwith contrast-enhanced ultrasonography using Sonazoid
Joshita, Satoru; Ichijo, Tetsuya; Suzuki, Fumitaka; Yokoyama, Takahide; Sugiyama, Yukiko; Fukushima, Mana; Kamijo, Atsushi; Komatsu, Michiharu; Umemura, Takeji; Yoshizawa, Kaname; Miyagawa, Shinichi; Tanaka, Eiji
HEPATOLOGY RESEARCH, 39(2), 207-212, 2009年02月

Abscess of the Round Ligament of the Liver Associated with Acute Obstructive Cholangitis and Septic Thrombosis
Arakura, Norikazu; Ozaki, Yayoi; Yamazaki, Sachie; Ueda, Kazuhiko; Maruyama, Masafumi; Chou, Yoshimi; Kodama, Ryo; Takayama, Mari; Hamano, Hideaki; Tanaka, Eiji; Kawa, Shigeyuki
INTERNAL MEDICINE, 48(21), 1885-1888, 2009年

Primitive Neuroectodermal Tumor as a Differential Diagnosis of CD56-Positive Tumors in Adults
Nagaya, Tadanobu; Tanaka, Naoki; Kamijo, Atsushi; Joshita, Satoru; Nakazawa, Koh; Miyabayashi, Hideharu; Yoneda, Suguru; Ito, Tetsuya; Komatsu, Michiharu; Tanaka, Eiji; Kitano, Kiyoshi
INTERNAL MEDICINE, 48(15), 1267-1272, 2009年

Pancreaticobiliary Fistula Evident after ESWL Treatment of Pancreatolithiasis
Arakura, N; Ozaki, Y; Maruyama, M; Chou, Y; Kodama, R; Takayama, M; Hamano, H; Tanaka, E; Kawa, S
INTERNAL MEDICINE, 48(7), 545-549, 2009年

Highly purified eicosapentaenoic acid treatment improves nonalcoholic steatohepatitis
Tanaka, N; Sano, K; Horiuchi, A; Tanaka, E; Kiyosawa, K; Aoyama, T
JOURNAL OF CLINICAL GASTROENTEROLOGY, 42(4), 413-418, 2008年

Mortality secondary to fulminant hepatic failure in patients with prior resolution of hepatitis B virus infection in Japan
Umemura, T; Tanaka, E; Kiyosawa, K; Kumada, H
CLINICAL INFECTIOUS DISEASES, 47(5), E52-E56, 2008年

Insulin resistance and hepatitis C virus: a case-control study of non-obese, non-alcoholic and non-steatotic hepatitis virus carriers with persistently normal serum aminotransferase
Tanaka, N; Nagaya, T; Komatsu, M; Horiuchi, A; Tsuruta, G; Shirakawa, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Aoyama, T; Kiyosawa, K; Tanaka, E
LIVER INTERNATIONAL, 28(8), 1104-1111, 2008年

Anti-Helicobacter pylori seropositivity: influence on severity and treatment response in patients with chronic hepatitis C
Umemura, T; Muto, H; Tanaka, E; Matsumoto, A; Ichijo, T; Yoshizawa, K; Akamatsu, T; Kiyosawa, K
JOURNAL OF VIRAL HEPATITIS, 14(1), 48-54, 2007年

Lack of association between FCRL3 and Fc gamma RII polymorphisms in Japanese type 1 autoimmune hepatitis
Umemura, T; Ota, M; Yoshizawa, K; Katsuyama, Y; Ichijo, T; Tanaka, E; Kawa, S; Kiyosawa, K
Clinical Immunology, 122(3), 338-342, 2007年

Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
Sugauchi, F; Orito, E; Ohno, T; Tanaka, Y; Ozasa, A; Kang, JH; Toyoda, J; Kuramitsu, T; Suzuki, K; Tanaka, E; Akahane, Y; Ichida, T; Izumi, N; Inoue, K; Hoshino, H; Iino, S; Yotsuyanagi, H; Kakumu, S; Tomita, E; Okanoue, T; Nishiguchi, S; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sata, M; Miyakawa, Y; Ueda, R; Mizokami, M
HEPATOLOGY RESEARCH, 36(2), 107-114, 2006年

A genome-wide DNA microsatellite association study of autoimmune hepatitis type 1 in Japan
Yoshizawa, K; Yokosawa, S; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Matsumoto, A; Tanaka, E; Kiyosawa, K
Hepatology, 44(4), 228A-228A, 2006年

Influence of hepatitis B virus genotypes as well as precore and core-promoter mutations on fulminant outcome of acute infection
Sugauchi, F; Orito, E; Tanaka, Y; Ozasa, A; Kang, JH; Toyoda, J; Yotsuyanagi, H; Iino, S; Kuramitsu, T; Suzuki, K; Tanaka, E; Akahane, Y; Izumi, N; Inoue, K; Kakumu, S; Tomita, E; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sata, M; Okanoue, T; Nishiguchi, S; Miyakawa,Y; Mizokami, M
Hepatology, 44(4), 539A-539A, 2006年

Influence of genotypes and precore mutations on fulminant or chronic outcome of acute hepatitis B virus infection
Ozasa, A; Tanaka, Y; Orito, E; Sugiyama, M; Kang, JH; Hige, S; Kuramitsu, T; Suzuki, K; Tanaka, E; Okada, S; Tokita, H; Asahina, Y; Inoue, K; Kakumu, S; Okanoue, T; Murawaki, Y; Hino, K; Onji, M; Yatsuhashi, H; Sakugawa, H; Miyakawa, Y; Ueda, R; Mizokami, M
Hepatology, 44(2), 326-334, 2006年

Timing of interferon therapy and sources of infection in patients with acute hepatitis C
Ogata, K; Ide, T; Kumashiro, R; Kumada, H; Yotsuyanagi, H; Okita, K; Akahane, Y; Kaneko, S; Tsubouchi, H;Tanaka, E; Moriwaki, H; Nishiguchi, S; Kakumu, S; Mizokami, M; Iino, S; Sata, M
HEPATOLOGY RESEARCH, 34(1), 35-40, 2006年

Hepatitis B virus RNA is measurable in serum and can be a new marker for monitoring lamivudine therapy
Rokuhara, A; Matsumoto, A; Tanaka, E; Umemura, T; Yoshizawa, K; Kimura, T; Maki, N; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY, 41(8), 785-790, 2006年

Useful parameters for distinguishing nonalcoholic steatohepatitis with mild steatosis from cryptogenic chronic hepatitis in the Japanese population
Tanaka, N; Tanaka, E; Sheena, Y; Komatsu, M; Okiyama, W; Misawa, N; Muto, H; Umemura, T; Ichijo, T; Matsumoto, A; Yoshizawa, K; Horiuchi, A; Kiyosawa, K
LIVER INTERNATIONAL, 26(8), 956-963, 2006年

Fulminant hepatitis after allogenic bone marrow transplantation caused by reactivation of hepatitis B virus with gene mutations in the core promotor region
Kitano, K; Kobayashi, H; Hanamura, M; Furuta, K; Ueno, M; Rokuhara, A; Tanaka, E; Umemura, T; Kiyosawa, K
EUROPEAN JOURNAL OF HAEMATOLOGY, 77(3), 255-258, 2006年

Laparoscopic findings in patients with nonalcoholic steatohepatitis
Tanaka, N; Ichijo, T; Okiyama, W; Mutou, H; Misawa, N; Matsumoto, A; Yoshizawa, K; Tanaka, E; Kiyosawa, K
LIVER INTERNATIONAL, 26(1), 32-38, 2006年

Measurement of hepatitis B virus core-related antigen is valuable for identifying patients who are at low risk of lamivudine resistance
Tanaka, E; Matsumoto, A; Suzuki, F; Kobayashi, M;Mizokami, M; Tanaka, Y; Okanoue, T; Minami, M; Chayama, K; Imamura, M; Yatsuhashi, H; Nagaoka, S; Yotsuyanagi, H; Kawata, S; Kimura, T; Maki, N; Iino, S; Kiyosawa, K
LIVER INTERNATIONAL, 26(1), 90-96, 2006年

Patients with and without loss of hepatitis B virus DNA after hepatitis B e antigen seroconversion have different virological characteristics
Misawa, N; Matsumoto, A; Tanaka, E; Rokuhara, A; Yoshizawa, K; Umemura, T; Maki, N; Kimura, T; Kiyosawa, K
JOURNAL OF MEDICAL VIROLOGY, 78(1), 68-73, 2006年

Assessment of KL-6 as a tumor marker in patients with hepatocellular carcinoma
Gad A, Tanaka E, Matsumoto A, Wahab MA, Serwah Ael-H, Attia F, Ali K, Hassouba H, el-Deeb Ael-R, Ichijyo T, Umemura T, Muto H, Yoshizawa K, Kiyosawa K
WorldJ Gastroenterol, 14, 6607-6612, 2005年

Ethnicity affects the diagnostic validity of alpha-fetoprotein in hepatocellular carcinoma
Gad A, Tanaka E, Matsumoto A, Serwah Ael-H , Attia F , Hassan A, Ali K , Abbas A, el-Deeb Ael- , Sun X, Umemura T, Ichijyo T, Ehara T, Yoshizawa K, Kiyosawa K
Asia-Pacific Journal of clinical oncology, 1, 64-70, 2005年

当科における肝細胞癌に対するラジオ波焼灼術の実態
一條哲也，沖山　洋，武藤英知，三沢倫子，梅村武司，松本晶博，吉澤　要，田中榮司，清澤研道
長野県医学会雑誌, 35, 38-39, 2005年

信州大学病院において－ウィルス性肝炎移植の現状と問題点－
田中榮司
今日の移植, 18, 216-219, 2005年

E型肝炎ウィルス（HEV）マーカー　広範囲血液・尿化学検査，免疫学的検査
田中榮司
日本臨床, 63, 421-423, 2005年

【生活習慣病と非アルコール性脂肪肝炎(NASH)】脂肪肝と肝移植
田中直樹，田中榮司，清澤研道
Progress inMedicine, 25, 1657-1660, 2005年

【C型肝炎の最新治療　治療方針のたて方と治療効果】治療方針とその効果　高ウイルス量の患者への治療方針と効果
松本晶博，田中榮司，清澤研道
消化器の臨床, 8, 180-183, 2005年

ウィルス性肝炎の治療の最前線
四柳　宏，田中榮司，横須賀　収
ヒューマンサイエンス, 16, 4-10, 2005年

Identification of novel HCV subgenome replicating persistently in chronic active hepatitis C patients
Yagi S, Mori K, Tanaka E, Matsumoto A, Sunaga F, Kiyosawa K, Yamaguchi K
J Med Virol, 77(3), 399-413, 2005年

Identification and quantitative analysis of a 22-KDA precore protein lacking C-terminal arginine-rich domain in hepatitis B virus DNA-negative Dane particles.
Kimura, T; Ohue, C; Ohno, N; Terada, N; Ohno, S; Akinori, R; Matsumoto, A; Tanaka, E; Kiyosawa, K; Maki, N
Hepatology, 42(4), 708A-708A, 2005年

Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan
Orito, E; Sugauchi, F; Tanaka, Y; Ichida, T; Sata, M; Tanaka, E; Okanoue, T; Sakugawa, H; Watanabe, H; Miyakawa, H; Nishiguchi, S; Kumada, H; Ueda, R; Mizokami, M
INTERVIROLOGY, 48(4), 239-245, 2005年

Characterization of hypervariable region in hepatitis C virus envelope protein during acute and chronic infection
Higashi, K; Tsukiyama-Kohara, K; Tanaka, T; Tanaka, E; Kiyosawa, K; Kohara, M
ARCHIVES OF VIROLOGY, 150(5), 883-898, 2005年

Hepatitis B virus core and core-related antigen quantitation in Chinese patients with chronic genotype B and C hepatitis B virus infection
Rokuhara A, Sun X, Tanaka E, Kimura T, Matsumoto A, Yao D, Yin L, Wang N, Maki N, Kiyosawa K
J Gastroenterol Hepatol, 20(11), 1726-1730, 2005年

Nucleotide mutations associated with hepatitis B e antigen negativity
Sun X, Rokuhara A, Tanaka E, Gad A, Mutou H, Matsumoto A, Yoshizawa K, Kiyosawa K
J Med Virol, 76(2), 170-175, 2005年

Genetic analysis of the HLA region of Japanese patients with type 1 autoimmune hepatitis
Yoshizawa K, Ota M, Katsuyama Y, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K
J Hepatol, 42(4), 578-584, 2005年

Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients
Matsumoto, A; Tanaka, E; Rokuhara, A; Kiyosawa, K; Kumada, H; Omata, M; Okita, K; Hayashi, N; Okanoue, T; Iino, S; Tanikawa, K
HEPATOLOGY RESEARCH, 32(3), 173-184, 2005年

Age-specific antibody to hepatitis E virus has remained constant during the past 20 years in Japan
Tanaka, E; Matsumoto, A; Takeda, N; Li, TC; Umemura, T; Yoshizawa, K; Miyakawa, Y; Miyamura, T; Kiyosawa, K
JOURNAL OF VIRAL HEPATITIS, 12(4), 439-442, 2005年

Hepatitis B virus DNA-negative Dane particles lack core protein but contain a 22-kDa precore protein without C-terminal arginine-rich domain
Kimura, T; Ohno, N; Terada, N; Rokuhara, A; Matsumoto, A; Yagi, S; Tanaka, E; Kiyosawa, K; Ohno, S; Maki, N
JOURNAL OF BIOLOGICAL CHEMISTRY, 280(23), 21713-21719, 2005年

Wilson病の治療と発症予防
梅村武司，田中栄司，清澤研道
肝臓, 45, 459-462, 2004年

SENウイルス(SEN V)の分子生物学
梅村武司，田中栄司
日本臨床, 62, 596-597, 2004年

我が国におけるSENウイルス感染の状況とその背景
梅村武司，田中栄司
日本臨床, 62, 602-605, 2004年

C型肝炎ウイルス　特殊型C型肝炎の臨床特論　HCV,HGV重複感染の疫学
折井幸司，田中栄司，清澤研道
日本臨床, 62, 677-681, 2004年

B型肝炎の治療　B型肝炎診療Q&A　HBe抗原陽性，高ウイルス量のB型慢性肝炎症例にいかに対処するか
田中栄司
臨床医, 30, 1601-1603, 2004年

B型慢性肝炎　HBe抗原陰性，肝機能異常を繰り返す症例に対する冶療
田中栄司
肝臓, 45, 397-401, 2004年

C型肝炎　最近の動向
田中栄司
看護技術, 50, 11-15, 2004年

C型肝炎ウイルス(HCV) HCV抗原測定法　HCVコア抗原測定法とその臨床的有用性
田中栄司
日本臨床, 62, 208-213, 2004年

E型肝炎の概論
田中栄司
日本臨床, 62, 536-541, 2004年

B型肝炎の治療up to date ラミブジン治療は肝発癌過程を修飾するか
松本晶博，田中栄司，清澤研道
臨床消化器内科, 191, 1507-1512, 2004年

C型肝炎ウイルス(HCV) C型慢性肝炎　予後に関連する因子の解析臨床検査データ
松本晶博，田中栄司，清澤研道
日本臨床, 62, 430-433, 2004年

Hepatitis B virus covalently closed circuler DNAの定療法と臨床的意義
向出雅一，松本晶博，六波羅明紀，田中栄司，竹村一男，兒崎隆純，引地一昌，清澤研道
SRL宝函, 28, 175-179, 2004年

C型肝硬変.血小板滅少例(血小板数58000～85000/μ 1)に対する少量INF-β療法の治療成績
山浦高裕，一條哲也，海野　洋，岡庭信司，中村喜行，太田裕志，松尾恭介，六波羅明紀，松本晶博，吉澤　要，田中栄司，清澤研道
飯田市立病院医誌, 10, 21-24, 2004年

Peroxisome proliferator-activated receptor a protects against alcohol-induced liver damage
Nakajima T, Kamijo Y, Tanaka N, Sugiyama E, TanakaE, Kiyosawa K, Fukushima Y, Peters JM, Gonzalez FJ, Aoyama T
Hepatology, 40(4), 972-980, 2004年

Interferon therapy for aged patients with chronic hepatitis C: improved survival in patients exhibiting abiochemical response
Imai Y, Kasahara A, Tanaka H, Okanoue T, Hiramatsu N, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Sasaki Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N
J Gastroenterol, 39(11), 1069-1077, 2004年

Inteferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death
Kasahara A, Tanaka H, Okanoue T, Imai Y, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N
J ViralHepat, 11(2), 148-156, 2004年

Hepatocellular carcinoma: recent trends in Japan
Kiyosawa K, Umemura T, Ichijo T, Matsumoto A, Yoshizawa K, Gad A, Tanaka E
Gastroenteroiogy, 127(5), S17-S26, 2004年

Nagano Interferon Treatment Research Group: Types of human leukocyte antigen and decrease in HCV core antigen in serum for predicting efficacy of interferon-Alpha in patients with chronic hepatitis C:analysis by a prospective study
Muto H, Tanaka E, Matsumoto A, Yoshizawa K, Kiyosawa K
J Gastroenterol, 39(7), 674-680, 2004年

Ribavirin-induced pure red-cell aplasia during treatment of chronic hepatitis C
Tanaka .N, Ishida F, Tanaka E
N Engl J Med, 350(12), 1264-1265, 2004年

Hepatic hydrothorax in the absence of ascites diagnosed by intraperitoneal spraying of indocyanine green
Umino J, Tanaka E, Ichijoh T, Muraki T, Orii K, Yoshizawa K, Kiyosawa K
Intem Med, 43(4), 283-288, 2004年

Hepatitis B virus genotype G is an extremely rare genotype in Japan
Kato, H; Sugauchi, F; Ozasa, A; Kato, T; Tanaka, Y; Sakugawa, H; Sata, M; Hino, K; Onji, M; Okanoue, T; Tanaka, E; Kawata, S; Suzuki, K; Hige, S; Ohno, T; Orito, E; Ueda, R; Mizokami, M
HEPATOLOGY RESEARCH, 30(4), 199-203, 2004年

その他のウイルスによる肝炎
梅村武司，田中榮司
臨床医, 29, 645-647, 2003年

成人生体肝移植・ウイルス肝炎術後再発　予防と治療
清澤研道，田中榮司
今日の移植, 16, 473-478, 2003年

C型肝炎診断の新展開
田中榮司
Medical Technology, 31, 138-144, 2003年

NASHの成因と病態　肝炎ウイルスとNASH
田中直樹，田中榮司，清澤研道
臨床消化器内科, 18, 1269-1274, 2003年

Crohn病の良性狭窄病変に対する内視鏡的バルーン拡張術の検討
村木　崇，赤松泰次，横澤秀一，三澤倫子，立岩伸之，進士明宏，小松健一，川村葉子，高山真理，浜野英明，越知泰英，中村　直，吉澤　要，田中榮司，清澤研道
ENDOSCOPIC FORUM for digestive disease, 19, 167-173, 2003年

B型慢性肝炎に対するラミブジン治療のウイルス学的効果予測式の作成
六波羅明紀，松本晶博，武藤英知，沖山　洋，田中直樹，丸山敦史，山浦高裕，折井幸司，一條哲也，吉澤　要，小林正和，袖山　健，田中榮司，清澤研道
肝臓, 44, 182-183, 2003年

Clinical significance of SEN virus infection in patients on maintenance haemodialysis
Kobayashi N, Tanaka E, Umemura T, Matsumoto A, Iijima T, Higuchi M, Hora K, Kiyosawa K
Nephrol Dial Transplant, 18(2), 348-352, 2003年

Factors predisposing to the occurrence of cryoglobulinemia in two cohorts of Egyptian and Japanese patients with chronic hepatitis C infection: ethnic and genotypic influence
Gad A, Tanaka E, Matsumoto A, el-Hamid Serwah A, Ali K, Makledy F, el-Gohary A, Orii K, Ijima A, Rokuhara A, Yoshizawa K, Nooman Z, Kiyosawa K
J Med Virol, 70(4), 594-599, 2003年

New enzyme immunoassay for detection of hepatitis B virus core antigen (HBcAg) and relation between levels of HBcAg and HBV DNA
Kimura T, Rokuhara A, Matsumoto A, Yagi S, Tanaka E, Kiyosawa K, Maki N
J Clin Microbiol, 41(5), 1901-1906, 2003年

Seroepidemiology of Helicobacter pylori and hepatitis A virus and the mode of transmission of infection: a 9-year cohort study in rural Japan
Malaty HM, Tanaka E, Kumagai T, Ota H, Kiyosawa K, Graham DY, Katsuyama T
Clin Infect Dis, 37(8), 1067-1072, 2003年

Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; a marker distinct from viral DNA for monitoring lamivudine treatment
Rokuhara A, Tanaka E, Matsumoto A, Kimura T, Yamaura T, Orii K, Sun X, Yagi S, Maki N, Kiyosawa K
J Viral Hepat, 10(4), 324-330, 2003年

Investigation of SEN virus infection in patients with cryptogenic acute liver failure, hepatitis-associated aplastic anemia, or acute and chronic non-A-E hepatitis
Umemura T, Tanaka E, Ostapowicz G, Brown KE, Heringlake S, Tassopoulos NC, Wang RY, Yeo AE, Shih JW, Orii K, Young NS, Hatzakis A, Manns MP, Lee WM, Kiyosawa K, Alter HJ
J Infect Dis, 188(10), 1545-1552, 2003年

A case-control study for early prediction ofhepatitis B e antigen seroconversion by hepatitis B virus DNA levels and mutations in the precore region and core promoter
Yamaura T, Tanaka E, Matsumoto A, Rokuhara A, Orii K, Yoshizawa K, Miyakawa Y, Kiyosawa K
J Med Virol, 70(4), 545-552, 2003年

Long-term follow-up of hepatitis C virus infection: HLA class II loci influences the natural history of the disease
Yoshizawa K, Ota M, Saito S, Maruyama A, Yamaura T, Rokuhara A, Orii K, Ichijo T, Matsumoto A, Tanaka E, Kiyosawa K
Tissue Antigens, 61(2), 159-165, 2003年

Clinical evaluation of a new enzyme immunoassay for hepatitis B virus core-related antigen; A marker distinct from viral DNA for monitoring lamivudine treatment.
Rokuhara, A; Kimura, T; Matsumoto, A; Tanaka, E; Maki, N; Kiyosawa, K
Hepatology, 38(4), 726A-727A, 2003年

Analysis of the genotype-determining region of hepatitis A viral RNA in relation to disease severities
Fujiwara, K; Yokosuka, O; Imazeki, F; Saisho, H; Saotome, N; Suzuki, K; Okita, K; Tanaka, E; Omata, M
HEPATOLOGY RESEARCH, 25(2), 124-134, 2003年

Riskfactors contributing to early and date phase intrahepatic recurrence of hepatocellular carcinoma after hepatectomy
Imamura, H; Matsuyama, Y; Tanaka, E; Ohkubo, T; Hasegawa, K; Miyagawa, S; Sugawara, Y; Minagawa, M; Takayama, T; Kawasaki, S; Makuuchi, M
JOURNAL OF HEPATOLOGY, 38(2), 200-207, 2003年

NASHと非A非B非C型肝炎ウイルス
田中直樹，田中榮司，清澤研道
肝・胆・膵, 44, 471-476, 2002年

HCV感染の診断と検査　HCVコア抗原定量とHCVセログループ　その利用法
田中榮司
臨床医, 28, 47-49, 2002年

HCV関連マーカー測定法の進歩
田中榮司
臨床検査, 46, 243-250, 2002年

ウイルス性肝炎の現況　SENウイルスとその臨床的意義
田中榮司
医学のあゆみ, 200, 33-36, 2002年

慢性肝炎診療マニュアルをめぐって　肝炎ウイルスの血液感染/母子感染/その他
田中榮司
綜合臨床, 51, 1929-1934, 2002年

2度の帝王切開を契機に増悪したと考えられる巨大肝血管腫によるKasabach-Merritt症候群の1例
六波羅明紀，吉澤　要，山浦高裕，丸山敦史，折井幸司，一條哲也，田中榮司，角谷眞澄，清澤研道
肝臓, 43, 185-191, 2002年

Clinical significance of TT virus infection in maintenance hemodialysis patients of an endemic area for hepatitis C infection
Gad A, Tanaka E, Orii K, Rokuhara A, Nooman Z, El-Hamid Serwah A,El-Sherif A, El-Essawy M, Yoshizawa K, Kiyosawa K
Hepatol Res, 22(1), 13-19, 2002年

Epidemiology and clinical aspects on hepatitis C
Higuchi M, Tanaka E, Kiyosawa K
Jpn J Infect Dis, 55(3), 69-77, 2002年

Sensitive enzyme immunoassay for hepatitis B virus core-related antigens and their correlation to virus load
Kimura T, Rokuhara A, Sakamoto Y, Yagi S, Tanaka E, Kiyosawa K, Maki N
J Clin Microbiol, 40(2), 439-445, 2002年

Characteristics of hepatocellular carcinoma in Japan
Kiyosawa K, Tanaka E
ONCOLOGY, 62, 5-7, 2002年

SEN virus: response to interferon alfa and influence on the severity and treatment response of coexistent hepatitis C
Umemura T, Alter HJ, Tanaka E, Orii K, Yeo AE, Shih JW, Matsumoto A, Yoshizawa K, Kiyosawa K
Hepatology, 35(4), 953-959, 2002年

Development of small hepatocellular carcinoma in a patient with chronic hepatitis C after 77 months of a sustained and complete response to interferon therapy
Yamaura T, Matsumoto A, Rokuhara A, Ichijo T, Tanaka E, Hanazaki K, Kajikawa S, Kiyosawa K
J Gastroenterol Hepatol, 17(11), 1229-1235, 2002年

Peroxisome proliferator-activated receptor gamma ligand troglitazone induces cell cycle arrest and apoptosis of hepatocellular carcinoma cell lines
Yoshizawa K, Cioca DP, Kawa S, Tanaka E, Kiyosawa K
Cancer, 95(10), 2243-2251, 2002年

The role of SEN virus infection in various liver diseases from different geographical regions.
Umemura, T; Tanaka, E; Lee, WM; Ostapowicz, G; Heringlake, S; Manns, MP; Tasopoulos, NC; Hatzakis, A; Brown, KE; Young, NS; Wang, R; Yeo, A; Shih, J; Orii, K; Kiyosawa, K; Alter, HJ
Hepatology, 36(4), 646A-646A, 2002年

Soluble asialoglycoprotein receptors reflect the apoptosis of hepatocytes
Kakegawa, T; Ise, H; Sugihara, N; Nikaido, T; Negishi, N; Akaike, T; Tanaka, E
CELL TRANSPLANTATION, 11(5), 407-415, 2002年

Relationship between hepatitis C virus infection and schistosomal liver disease: not simply an additive effect
Gad, A; Tanaka, E; Orii, K; Rokuhara, A; Nooman, Z; Serwah, AH; Shoair, M; Yoshizawa, K; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY, 36(11), 753-758, 2001年

Association between SEN virus infection and hepatitis C in Japan
Umemura, T; Alter, HJ; Tanaka, E; Yeo, AET; Shih, JWK; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K
JOURNAL OF INFECTIOUS DISEASES, 184(10), 1246-1251, 2001年

SEN virus infection in high- and non-endemic areas for hepatitis C in Japan.
Umemura, T; Alter, HJ; Tanaka, E; Yeo, AE; Shih, JW; Orii, K; Matsumoto, A; Yoshizawa, K; Kiyosawa, K
Hepatology, 34(4), 487A-487A, 2001年

8-year birth cohort study of the seroepidemiology of Helicobacter pylori infection and hepatitis A virus in rural Japan
Malaty, HM; Tanaka, E; Kumagai, T; Ota, H; Akamatsu, T; Kiyosawa, K; Graham, DY
Gut, 49, A32-A32, 2001年

Geographic distribution of hepatitis B virus (HBV) genotype in patients with chronic HBV infection in Japan
Orito, E; Ichida, T; Sakugawa, H; Sata, M; Horiike, N; Hino, K; Okita, K; Okanoue, T; Iino, S; Tanaka, E; Suzuki, K; Watanabe, H; Hige, S; Mizokami, M
Hepatology, 34(3), 590-594, 2001年

Development of a sensitive enzyme-immunoassay for hepatitis B virus core-related antigens.
Kimura, T; Rokuhara, A; Sakamoto, Y; Yagi, S; Tanaka, E; Kiyosawa, K; Maki, N
CLINICAL CHEMISTRY, 47(6), A94-A94, 2001年

A birth cohort study of the seroepidemiologic association of Helicobacter pylori infection and Hepatitis A virus in rural Japan
Malaty, HM; Tanaka, E; Kumagai, T; Ota, H; Akamatsu, ET; Kiyosawa, K; Graham, DY; Katsuyama, T
GASTROENTEROLOGY, 120(5), A128-A128, 2001年

Hepatocarcinogenesis inhibition by caffeine in ACI rats treated with 2-acetylaminofluorene
Hosaka, S; Kawa, S; Aoki, Y; Tanaka, E; Yoshizawa, K; Karasawa, Y; Hosaka, N
FOOD AND CHEMICAL TOXICOLOGY, 39(6), 557-561, 2001年

Strategy for lamivudine-resistant YMDD mutant-associated chronic hepatitis B
Kiyosawa, K; Tanaka, E
JOURNAL OF GASTROENTEROLOGY, 36(2), 139-141, 2001年

Seroepidemiological study of hepatitis E virus infection in Japan using a newly developed antibody assay
Tanaka E　他10名
J Gastroenterol, 36(5), 317-321, 2001年

Natural history of acute hepatitis C
Tanaka E　他1
J Gastroenterol Hepatol, 15 (suppl), E97-E104, 2000年

Clinical significance of TT virus infection in patients with chronic liver disease and volunteer blood donors in Egypt
Amal G, Tanaka E　他6名
J Med Virol, 60(2), 177-181, 2000年

Persistent infection mechanism of GB virus C/hepatitis G virus differs from that of hepatitis C virus
Orii K, Tanaka E　他5名
INTERVIROLOGY, 43(3), 139-145, 2000年

Evaluation of a new enzyme immunoassay for hepatitis C virus (HCV) core antigen with clinical sensitivity approximating that of genomic amplification of HCV RNA
Tanaka E　他6名
Hepatology, 32(2), 388-393, 2000年

Clinical impact of genotype 1 TT virus infection in patients with chronic hepatitis C and response of TT virus to alpha-interferon
Nishizawa, Y; Tanaka, E; Orii, K; Rokuhara, A; Ichijo, T; Yoshizawa, K; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 15(11), 1292-1297, 2000年

The prevalence of SEN virus infection in Japanese patients with viral hepatitis and liver disease.
Umemura, T; Yeo, AE; Shih, Y; Matsumoto, A; Orii, K; Tanaka, E; Kiyosawa, K; Primi, D
Hepatology, 32(4), 381A-381A, 2000年

De novo infection of hepatitis B virus in patients with orthotopic liver transplantation analysis by determining the complete sequence of the genome.
Rokuhara, A; Tanaka, E; Yagi, S; Mizokami, M; Hashikura, Y; Kawasaki, S; Kiyosawa, K
Hepatology, 32(4), 597A-597A, 2000年

De novo infection of hepatitis B virus in patients with orthotopic liver transplantation: Analysis by determining complete sequence of the genome
Rokuhara, A; Tanaka, E; Yagi, S; Mizokami, M; Hashikura, Y; Kawasaki, S; Kiyosawa, K
JOURNAL OF MEDICAL VIROLOGY, 62(4), 471-478, 2000年

The role of hepatitis C virus infection in glomerulopathy
Muramatsu, T; Hora, K; Ako, S; Tachibana, N; Hora, K; Tanaka, E
HEPATOLOGY RESEARCH, 18(3), 190-202, 2000年

A new era of interferon treatment for chronic hepatitis C is coming
Kiyosawa, K; Tanaka, E
JOURNAL OF GASTROENTEROLOGY, 35(8), 652-654, 2000年

T cell repertoire in the liver of patients with primary biliary cirrhosis
Inada, H; Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Umemura, T; Tanaka, E; Kiyosawa, K
HUMAN IMMUNOLOGY, 61(7), 675-683, 2000年

Risk factors contributing to early and late phases of intrahepatic recurrence of hepatocellular carcinoma (HCC) after hepatectomy.
Imamura, H; Tanaka, E; Matsuyama, Y; Miyagawa, SI; Kawasaki, S; Kubota, K; Takayama, T; Makuuchi, M
GASTROENTEROLOGY, 118(4), A916-A916, 2000年

Analysis of T cell repertoire in the liver of patients with chronic hepatitis C
Umemura, T; Yoshizawa, K; Ota, M; Katsuyama, Y; Inada, H; Tanaka, E; Kiyosawa,K
CLINICAL AND EXPERIMENTAL IMMUNOLOGY, 121(1), 120-126, 2000年

Evidence from a nine-year birth cohort study in Japan of transmission pathways of Helicobacter pylori infection
Malaty, HM; Kumagai, T; Tanaka, E; Ota, H; Kiyosawa, K; Graham, DY; Katsuyama, T
JOURNAL OF CLINICAL MICROBIOLOGY, 38(5), 1971-1973, 2000年

Relationship between histological prognosis of chronic hepatitis C and amount of hepatitis C virus core protein in serum
Iijima, A; Tanaka, E; Kobayashi,M; Yagi, S; Mizokami, M; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 15(3), 311-319, 2000年

Does GBV-C/HGV replicate in the liver?
Tanaka, E
JOURNAL OF GASTROENTEROLOGY, 34(6), 721-723, 1999年

Dynamic analysis of hepatitis C virus replication and quasispecies selection in long-term cultures of adult human hepatocytes infected in vitro
Rumin, S; Berthillon, P; Tanaka, E; Kiyosawa, K; Trabaud, MA; Bizollon, T; Gouillat, C; Gripon, P; Guguen-Guillouzo, C; Inchauspe, G; Trepo, C
JOURNAL OF GENERAL VIROLOGY, 80, 3007-3018, 1999年

T cell repertoire in the liver ofpatients with autoimmune hepatitis
Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Umemura, T; Tanaka, E; Kiyosawa, K
HUMAN IMMUNOLOGY, 60(9), 806-815, 1999年

GB virus C/hepatitis G virus
Kiyosawa, K; Tanaka, E
INTERVIROLOGY, 42(2-3), 185-195, 1999年

Targeting of hepatitis C virus core protein for MHC I or MHC II presentation does not enhance induction of immune responses to DNA vaccination
Vidalin, O; Tanaka, E; Spengler, U; Trepo, C; Inchauspe, G
DNA AND CELL BIOLOGY, 18(8), 611-621, 1999年

Transfusion-associated TT virus infection and its relationship to liver disease
Matsumoto, A; Yeo, AET; Shih, JWK; Tanaka, E; Kiyosawa, K; Alter, HJ
Hepatology, 30(1), 283-288, 1999年

Development of a simple and highly sensitive enzyme immunoassay for hepatitis C virus core antigen
Aoyagi, K; Ohue, C; Iida, K; Kimura, T; Tanaka, E; Kiyosawa, K; Yagi, S
JOURNAL OF CLINICAL MICROBIOLOGY, 37(6), 1802-1808, 1999年

Prevalence and disease association of TT virus infection in Japanese patients with viral hepatitis
Orii, K; Tanaka, E; Umemura, T; Rokuhara, A; Iijima, A; Yoshizawa, K; Imai, H; Kiyosawa, K
HEPATOLOGY RESEARCH, 14(2), 161-170, 1999年

Transmission of and liver injury by TT virus in patients on maintenance hemodialysis
Oguchi, T; Tanaka, E; Orii, K; Kobayashi, M; Hora, K; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY, 34(2), 234-240, 1999年

TT virus infection in an area of high-endemicity for hepatitisC
Umemura, T; Tanaka, E; Ota, M; Orii, K; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
HEPATOLOGY RESEARCH, 13(3), 212-220, 1999年

Detection of GB virus-C hepatitis G virus genome in peripheral blood mononuclear cells and liver tissue
Kobayashi, M; Tanaka, E; Nakayama, J; Furuwatari, C; Katsuyama, T; Kawasaki, S; Kiyosawa, K
JOURNAL OFMEDICAL VIROLOGY, 57(2), 114-121, 1999年

Past and present hepatitis G virus infections in areas where hepatitis C is highly endemic and those where it is not endemic
Tanaka E　他8名
J Clin Microbiol, 36(1), 110-114, 1998年

Possible recurrence of primary sclerosing cholangitis following living-related liver transplantation: Report of a case
Kita, Y; Lake, JR; Ferrell, LD; Mori, M; Roberts, JP; Kakizoe, S; Kiyosawa, K; Tanaka, E; Shiga, J; Takikawa, H; Inoue, Y; Ohtake, T; Ohtomo, K; Yotsuyanagi, H; Oka, T; Harihara, Y; Takayama, T; Kubota, K; Kawarasaki, H; Hashikura, Y; Kawasaki, S; Ascher, NL; Makuuchi, M
TRANSPLANTATION PROCEEDINGS, 30(7), 3321-3323, 1998年

T cell receptor usage of liver infiltrating T cells in patients with autoimmune hepatitis.
Yoshizawa, K; Ota, M; Katsuyama, Y; Ichijo, T; Inada, H; Imai, H; Tanaka, E; Kiyosawa, K
Hepatology, 28(4), 191A-191A, 1998年

Clinical performance of quantitative and highly sensitive HCV core antigen assay system.
Tanaka, E; Aoyagi, K; Nishizawa, Y; Umemura, T; Orii, K; Rokuhara, A; Iijima, A; Imai, H; Yoshizawa, K; Yagi, S; Hasegawa, A; Kiyosawa, K
Hepatology, 28(4), 279A-279A, 1998年

Development of highly sensitive enzyme-immunoassay for hepatitis C virus core antigen.
Aoyagi, K; Ohue, C; Iida, K; Kimura, T; Tanaka, E; Kiyosawa, K; Yagi, S
Hepatology, 28(4), 568A-568A, 1998年

Acquistion vs. loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study
Kumagai, T; Malaty, HM; Ota, H; Tanaka, E; Akamatsu, T; Kiyosawa, K; Graham, DY; Katsuyama, T
Gut, 43, A39-A39, 1998年

An 8-year birth cohort study shows adult-to-child transmission of H-pylori infection
Malaty, HM; Kumagai, T; Ota, H; Tanaka, E; Akamatsu, T; Kiyosawa, K; Graham, DY; Katsuyama, T
Gut, 43, A40-A40, 1998年

Acquisition versus loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study
Kumagai, T; Malaty, HM; Graham, DY; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
JOURNAL OF INFECTIOUS DISEASES, 178(3), 717-721, 1998年

Prospective follow-up study of hepatitis C virus infection in patients undergoing maintenance haemodialysis: Comparison among haemodialysis units
Kobayashi, M; Tanaka, E; Oguchi, H; Hora, K; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 13(6), 604-609, 1998年

Clinical application of hepatitis C virus core protein in early diagnosis of acute hepatitis C
Kobayashi, M; Tanaka, E; Matsumoto, A; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY, 33(4), 508-511, 1998年

Two patients with acute hepatitis B with suspected sexual transmission of hepatitis G virus
Tanaka, E; Nakatsuji, Y; Kobayashi, M; Orii, K; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY, 33(3), 419-423, 1998年

Acquisition and loss of Helicobacter pylori infection in Japan: Results from an 8-year birth cohort study.
Kumagai, T; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
GASTROENTEROLOGY, 114(4), A190-A190, 1998年

Adult-to-child transmission of Helicobacter pylori infection: Results from an 8-year birth cohort study.
Malaty, HM; Graham, DY; Kumagai, T; Hosogaya, S; Misawa, K; Furihata, K; Ota, H; Sei, C; Tanaka, E; Akamatsu, T; Shimizu, T; Kiyosawa, K; Katsuyama, T
GASTROENTEROLOGY, 114(4), A211-A211, 1998年

Evolution of hepatitis G virus infection and antibody response to envelope protein in patients with transfusion-associated non-A, non-B hepatitis
TANAKA Eiji 他7名
J Viral Hepatitis, 5(3), 153-159, 1998年

Clinical significance of hepatitis G virus infection in patients on long-term haemodialysis
Ideura, T; Tanaka, E; Nakatsuji, Y; Kobayashi, M; Kanno, Y; Oguchi, H; Hora, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 12(11), 762-765, 1997年

Humoral immune response to the E2 protein of hepatitis G virus is associated with long-term recovery frominfection and reveals a high frequency of hepatitis G virus exposure among healthy blood donors
Tacke, M; Schmolke, S; Schlueter, V; Sauleda, S; Esteban, JI; Tanaka, E; Kiyosawa, K; Alter, HJ; Schmitt, U; Hess, G; OfenlochHaehnle, B; Engel, AM
Hepatology, 26(6), 1626-1633, 1997年

Past and present infections ofhepatitis G virus in high-endemic area for hepatitis C; Comparison with nonendemic area.
Tanaka, E; Tacke, M; Kobayashi, M; Nakatsuji, Y; Kiyosawa, K; Schmolke, S; Engel, AM; Hess, G; Alter, HJ
Hepatology, 26(4), 797-797, 1997年

Long-term prognosis of type C chronic hepatitis patients treated with interferon; Development of hepatocellular carcinoma.
Iijima, A; Sodeyama, T; Inada, H; Ichijo, T; Kobayashi, M; Yamada, S; Imai, H; Yoshizawa, K; Tanaka, E; Kiyosawa, K
Hepatology, 26(4), 1599-1599, 1997年

Hepatitis G virus GB virus C infection in an area of high endemic hepatitis C virus infection
Tanaka, E; Nakatsuji, Y; Kobayashi, M; Iijima, A; Ichijo, T; Imai, H; Yoshizawa, K; Sodeyama, T; Kiyosawa, K
HEPATOLOGY RESEARCH, 7(2), 130-135, 1997年

Quantitative measurement of HCV RNA in the serum: A comparison of three assays based on different principles
Ichijo, T; Matsumoto, A; Kobayashi, M; Furihata, K; Tanaka, E
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 12(7), 500-506, 1997年

A prospective trial to change the administration dose of interferon according to a decrease in serum HCV-RNA in chronic hepatitis C.
Sodeyama, T; Matsumoto, A; Tanaka, E; Iizima, A; Yoshizawa, K; Imai, H; Kiyosawa, K
GASTROENTEROLOGY, 112(4), A1386-A1386, 1997年

Autoimmune hepatitis type 1 without evidence of hepatitis G virus infection
Ichijo, T; Nakatsuji, Y; Tanaka, E; Alter, HJ; Yoshizawa, K; Imai, H; Sodeyama, T; Kiyosawa, K
INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 6(5), 219-224, 1997年

Antibody response to E2/NS1 hepatitis C virus protein in patients with acute hepatitis C
Kobayashi, M; Tanaka, E; Matsumoto, A; Ichijo, T; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 12(1), 73-76, 1997年

Hepatitis G virus GB virus C infection in patients with chronic non-B, non-C hepatitis
Tanaka, E; Yamaguchi, K; Uemura, K; Kobayashi, M; Iijima, A; Kiyosawa, K; Yagi, S; Hasegawa, A
INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 6(3-4), 137-143, 1997年

Effect of hepatitis G virus infection on chronic hepatitis C
Tanaka E　他8名
Ann Intern Med, 125(9), 740-743, 1996年

Serum levels of hepatitis C virus core protein in patients with chronic hepatitis C treated with interferon alfa
Tanaka E　他7名
Hepatology, 23(6), 1330-1333, 1996年

The natural course of chronic hepatitis C: a comparison between patients with genotypes 1 and 2 hepatitis C viruses
Kobayashi M, Tanaka E　他4名
Hepatology, 23(4), 695-699, 1996年

Budd-Chiari syndrome caused by hepatic vein thrombosis in a patient with myeloproliferative disorder
Usui, T; Kitano, K; Midorikawa, T; Yoshizawa, K; Kobayashi, H; Tanaka, E; Matsunami, H; Kawasaki, S; Kiyosawa, K
INTERNAL MEDICINE, 35(11), 871-875, 1996年

Prevalence and disease association of hepatitis G virus infection in Japan
Nakatsuji, Y; Shih, JWK; Tanaka, E; Kiyosawa, K; Wages, J; Kim, JP; Alter, HJ
JOURNAL OF VIRAL HEPATITIS, 3(6), 307-316, 1996年

Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis
Shimodaira, S; Ishida, F; Ichikawa, N; Tahara, T; Kato, T; Kodaira, H; Ito, T; Tanaka, E; Sodeyama, T; Kiyosawa, K; Kitano, K
THROMBOSIS AND HAEMOSTASIS, 76(4), 545-548, 1996年

Effect of hepatitis G virus co-infection on patients with chronic hepatitis C
Tanaka, E; Alter, HJ; Nakatsuji, Y; Shih, JWK; Kim, JP; Matsumoto, A; Kobayashi, M; Kiyosawa, K
Hepatology, 24(4), 400-400, 1996年

Hepatitis G virus (HGV) infection in Japanese patients infected with hepatitis C virus (HCV).
Nakatsuji, Y; Shih, JWK; Kobayashi, M; Tanaka, E; Kiyosawa, K; Kim, JP; Alter, HJ
Hepatology, 24(4), 403-403, 1996年

Lymphocyte proliferative responses to recombinant hepatitis C virus antigens in patients with chronic hepatitis C
Mori, H; Yabu, K; Yoshizawa, K; Tanaka, E; Kiyosawa, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 11(8), 697-704, 1996年

Detection of hepatitis C virus specific core protein in serum of patients by a sensitive fluorescence enzyme immunoassay (FEIA)
Kashiwakuma, T; Hasegawa, A; Kajita, T; Takata, A; Mori, H; Ohta, Y; Tanaka,E;Kiyosawa, K; Tanaka, T; Tanaka, S; Hattori, N; Kohara, M
JOURNAL OF IMMUNOLOGICAL METHODS, 190(1), 79-89, 1996年

Simple fluorescent enzyme immunoassay for detection and quantification of hepatitis C viremia
Tanaka, T; Lau, JYN; Mizokami, M; Orito, E; Tanaka, E; Kiyosawa, K; Yasui, K; Ohta, Y; Hasegawa, A; Tanaka, S; Kohara, M
JOURNAL OF HEPATOLOGY, 23(6), 742-745, 1995年

Serum thrombopoietin (c-Mpl ligand) levels in patients with liver cirrhosis
Shimodaira, S; Ishida, F; Ichikawa, N; Tahara, T; Kato, T; Kodaira, H; Ito, T; Tanaka, E; Sodeyama, T; Kiyosawa, K; Kitano, K
BLOOD, 86(10), 3621-3621, 1995年

EPIDEMIOLOGY OF GENOTYPES OF HEPATITIS-C VIRUS IN JAPANESE PATIENTS WITHTYPE-C CHRONIC LIVER-DISEASES - A MULTI-INSTITUTION ANALYSIS
TANAKA, E; KIYOSAWA, K; MATSUSHIMA, T; ISHIKAWA, K; HINO, K; TANAKA, S; NOSE, H; KUMADA, H; IINO, S; KAMIMURA, T; UNOURA, M; MIZOKAMI, M; OKANOUE, T; KUROKI, T; YAMADA, G; MIURA, T; YANO, M; TSUBOUCHI, H; KOHARA, M; SATO, S; HATTORI, N; FURUTA, S; KARINO, Y; SAINOKAMI, S; TANAKA, T; OKADA, S; CHAYAMA, K; YASUDA, K; KUWANA, K; KANEKO, S; MIZOGUCHI, N; YASUI, K; TAKEDA, T; KISHI, F; YATSUHASHI, H; MARUYAMA, T; TSUKIYAMAKOHARA, K
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 10(5), 538-545, 1995年

ACUTE HEPATITIS-C TRANSMITTED BY NEEDLESTICK ACCIDENT DESPITE SHORT-DURATION INTERFERON TREATMENT
NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; MATSUMOTO, A; ICHIJO, T; MIZOKAMI, M; FURUTA, S
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 10(5), 609-611, 1995年

PREVALENCE OF HEPATITIS-G VIRUS (HGV) IN JAPAN
NAKATSUJI, Y; SHIH, JWK; TANAKA, E; WAGES, J; KIYOSAWA, K; KIM, JP; ALTER, HJ
Hepatology, 22(4), 303-303, 1995年

CLINICAL-APPLICATION OF A FLUORESCENCE ENZYME-IMMUNOASSAY FOR HCV CORE PROTEIN
TANAKA, E; MATSUMOTO, A; KOBAYASHI, M; ICHIJO, T; IMAI, H; SODEYAMA, T; KIYOSAWA, K; OHTA, Y; HASEGAWA, A; KOHARA, M
Hepatology, 22(4), 995-995, 1995年

SIMPLE FLUORESCENT EIA FOR DETECTION AND QUANTIFICATION OF HEPATITIS-C VIREMIA
Tanaka, T; Lau, JYN; Mizokami, M; Orito, E; Tanaka, E; Kiyosawa, K; Yasui, K; Ohta, Y; Hasegawa, A; Tanaka, S; Kohara, M
Hepatology, 22(4), 996-996, 1995年

USEFULNESS OF SIMPLE ASSAYS FOR SERUM CONCENTRATION OF HEPATITIS-C VIRUS-RNA AND HCV GENOTYPE IN PREDICTING THE RESPONSE OF PATIENTS WITH CHRONIC HEPATITIS-C TO INTERFERON ALPHA-2A THERAPY
SUZUKI, T; TANAKA, E; MATSUMOTO, A; URUSHIHARA, A; SODEYAMA, T
JOURNAL OF MEDICAL VIROLOGY, 46(2), 162-168, 1995年

NATURAL-HISTORY OF HEPATITIS-C
KIYOSAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
INTERVIROLOGY, 37(2), 101-107, 1994年

IMMUNOPEROXIDASE STAINING OF HEPATITIS-C VIRUS IN FORMALIN-FIXED, PARAFFIN-EMBEDDED NEEDLE LIVER BIOPSIES
UCHIDA, T; SHIKATA, T; TANAKA, E; KIYOSAWA, K
VIRCHOWS ARCHIV-AN INTERNATIONAL JOURNAL OF PATHOLOGY, 424(5), 465-469, 1994年

PREVALENCE OF HEPATITIS-C VIRUS WITH DIFFERENT GENOTYPES DETERMINED BY A GROUP-SPECIFIC ANTIBODY-ASSAY IN JAPANESE PATIENTS WITH CHRONIC LIVER-DISEASES DUE TO HEPATITIS-C VIRUS-INFECTION
TANAKA, E; KIYOSAWA, K; MATSUMOTO, A; SODEYAMA, T; URUSHIHARA, A; SUZUKI, T; KOBAYASHI, M; FURUTA, S
JAPANESE JOURNAL OF MEDICAL SCIENCE&BIOLOGY, 47(1), 47-57, 1994年

VIRAL AND HOST FACTORS THAT CONTRIBUTE TO EFFICACY OF INTERFERON-ALPHA(2A) THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
MATSUMOTO, A; TANAKA, E; SUZUKI, T; OGATA, H; KIYOSAWA, K
DIGESTIVE DISEASES AND SCIENCES, 39(6), 1273-1280, 1994年

TRANSMISSION OF HEPATITIS-C IN AN ISOLATED AREA IN JAPAN - COMMUNITY-ACQUIRED INFECTION
KIYOSAWA, K; TANAKA, E; SODEYAMA, T; YOSHIZAWA, K; YABU, K; FURUTA, K; IMAI, H; NAKANO, Y; USUDA, S;UEMURA, K; FURUTA, S; WATANABE, Y; WATANABE, J; FUKUDA, Y; TAKAYAMA, T; URUSHIBARA, A; MATSUMOTO, A; MORI, H; KOBAYASHI, M; SUZUKI, T; YAMADA, S; SEKI, T; SHIMIZU, S; NAKAMURA, M; SONE, H; HARA, K; ICHIJO, T; OHIKE, Y; GIBO, Y; NAKATSUJI, Y; YODA, H; TSUCHIYA, K; HAYATA, T; IMAI, Y; KOBAYASHI, M; HARA, N
GASTROENTEROLOGY, 106(6), 1596-1602, 1994年

SERUM COLLAGEN TYPE-IVFOR THE ASSESSMENT OF FIBROSIS AND RESISTANCE TO INTERFERON THERAPY IN CHRONIC HEPATITIS-C
YABU, K; KIYOSAWA, K; MORI, H; MATSUMOTO, A; YOSHIZAWA, K; TANAKA, E; FURUTA, S
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 29(5), 474-479, 1994年

ADAPTATION OF HEPATITIS-C VIRUS FOR PERSISTENT INFECTION IN PATIENTS WITH ACUTE HEPATITIS
YAMAGUCHI, K; TANAKA, E; HIGASHI, K; KIYOSAWA, K; MATSUMOTO, A; FURUTA, S; HASEGAWA, A; TANAKA, S; KOHARA, M
GASTROENTEROLOGY, 106(5), 1344-1348, 1994年

SILENT HEPATITIS-B VIRUS MUTANTS ARE RESPONSIBLE FOR NON-A, NON-B, NON-C, NON-D, NON-E HEPATITIS
UCHIDA, T; SHIMOJIMA, M; GOTOH, K; SHIKATA, T; TANAKA, E; KIYOSAWA, K
MICROBIOLOGY AND IMMUNOLOGY, 38(4), 281-285, 1994年

CHANGES IN ANTIBODY-TITERS TO HEPATITIS-C VIRUS FOLLOWING INTERFERON THERAPY FOR CHRONIC INFECTION
URUSHIHARA, A; SODEYAMA, T; MATSUMOTO, A; TANAKA, E
JOURNAL OF MEDICAL VIROLOGY, 42(4), 348-356, 1994年

TYPE C CHRONIC HEPATITIS ASSOCIATED WITH THROMBOCYTOPENIA IN 2 PATIENTS
YABU, K; KIYOSAWA, K; AKO, S; USUDA, S; YOSHIZAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 9(1), 99-104, 1994年

QUANTITATIVE ASSAY FOR ANTI-HCV-CORE ANTIBODY IN HEALTHY-INDIVIDUALS FOUND ANTI-HCV POSITIVE DURING A MASS-SCREENING
URUSHIHARA, A; SUZUKI, T; MATSUMOTO, A; TANAKA, E; SODEYAMA, T; KIYOSAWA, K; FURUTA, S
INTERNATIONAL HEPATOLOGY COMMUNICATIONS, 2(1), 47-51, 1994年

HUMAN-LEUKOCYTE ANTIGEN CLASS-II MOLECULES AND PRIMARY BILIARY-CIRRHOSIS SUSCEPTIBILITY IN JAPANESE PATIENTS
SEKI, T; KIYOSAWA, K; OTA, M; FURUTA, S; FUKUSHIMA, H; TANAKA, E; YOSHIZAWA, K; MIZUKI, N; ANDO, A; INOKO, H
Hepatology, 18(4), A218-A218, 1993年

IMMUNE-RESPONSES TO HCV ANTIGENS OF THE PATIENTS WITH DIFFERENT HISTOLOGICAL STAGES IN CHRONIC HEPATITIS-C
MORI, H; YABU, K; YOSHIZAWA, K; USUDA, S; TANAKA, E; KIYOSAWA, K; HASEGAWA, A; KOHARA, M; FURUTA, S
Hepatology, 18(4), A245-A245, 1993年

FACTORS THAT CONTRIBUTE TO THE EFFICACY OF IFN THERAPY IN PATIENTS WITH CHRONIC HEPATITIS-C
TANAKA, E; MATSUMOTO, A; SUZUKI, T; URUSHIHARA, A; YOSHIZAWA, K; SODEYAMA, T; KIYOSAWA, K; FURUTA, S
Hepatology, 18(4), A258-A258, 1993年

LOW-PREVALENCE OF HEPATITIS-C VIRUS-INFECTION IN PATIENTS WITH AUTOIMMUNE HEPATITIS TYPE-1
TANAKA, E; KIYOSAWA, K; SEKI, T; MATSUMOTO, A; SODEYAMA, T; FURUTA, S; KUMAGAI, T; KOHARA, M
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 8(5), 442-447, 1993年

PROGNOSIS OF ASYMPTOMATIC HEPATITIS-B SURFACE-ANTIGEN CARRIERS
KIYOSAWA, K; SODEYAMA, T; TANAKA, E
ANNALS OF INTERNAL MEDICINE, 119(6), 535-535, 1993年

DETECTION OF HEPATITIS-C VIRUS MARKERS AND HEPATITIS-C VIRUS GENOMIC RNA AFTER NEEDLESTICK ACCIDENTS
SODEYAMA, T; KIYOSAWA, K; URUSHIHARA, A; MATSUMOTO, A; TANAKA, E; FURUTA, S; AKAHANE, Y
ARCHIVES OF INTERNAL MEDICINE, 153(13), 1565-1572, 1993年

ASSOCIATION OF PRIMARY BILIARY-CIRRHOSIS WITH HUMAN-LEUKOCYTE ANTIGEN-DPB1-ASTERISK-0501 IN JAPANESE PATIENTS
SEKI, T; KIYOSAWA, K; OTA, M; FURUTA, S; FUKUSHIMA, H; TANAKA, E; YOSHIZAWA, K; KUMAGAI, T; MIZUKI, N; ANDO, A; INOKO, H
Hepatology, 18(1), 73-78, 1993年

PROLIFERATIVE ACTIVITY OF HEPATOCYTES IN CHRONIC VIRAL-HEPATITIS AS REVEALED BY IMMUNOHISTOCHEMISTRY FOR PROLIFERATING CELL NUCLEAR ANTIGEN
NAKAMURA, T; HAYAMA, M; SAKAI, T; HOTCHI, M; TANAKA, E
HUMAN PATHOLOGY, 24(7), 750-753, 1993年

COMPARISON OF SEROEPIDEMIOLOGY OF HEPATITIS-C IN BLOOD-DONORS BETWEEN BANGLADESH AND JAPAN
KHAN, M; HUSAIN, M; YANO, M; HASHIZUME, K; YOUSUF, M; TANAKA, E; MATSUMOTO, A; FURUTA, S; KIYOSAWA, K
GASTROENTEROLOGIA JAPONICA, 28, 28-31, 1993年

ANTI-C100 ANTIBODIES TO HEPATITIS-C VIRUS IN PATIENTS WITH CHRONIC HEPATITIS-C VIRUS-INFECTION TREATED WITH INTERFERON
NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; YOSHIZAWA, K; FURUTA, K; NAKATSUJI, Y; URUSHIHARA, A; FURUTA, S
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 28(4), 335-342, 1993年

COMPARISON OF THE CLINICAL AND IMMUNOGENETIC FEATURES BETWEEN PATIENTS WITH AUTOIMMUNE HEPATITIS AND PATIENTS WITH TYPE-C CHRONICACTIVE HEPATITIS
KIYOSAWA, K; SEKI, T; TANAKA, E; SODEYAMA, T; FURUTA, K; FURUTA, S; HINO, K; OTA, M; INOKO, H
GASTROENTEROLOGIA JAPONICA, 28, 63-68, 1993年

CLINICAL-SIGNIFICANCE OF ANTIBODIES TO NONSTRUCTURAL AND CORE PROTEINS OF HEPATITIS-C VIRUS IN POSTTRANSFUSION HEPATITIS PATIENTS DURING LONG-TERM FOLLOW-UP
TANAKA, E; KIYOSAWA, K; NAKATSUJI, Y; INOUE, Y; MIYAMURA, T; CHIBA, J; FURUTA, S
JOURNAL OF MEDICAL VIROLOGY, 39(4), 318-324, 1993年

CAROLIS-DISEASE IN 3 SIBLINGS
YOSHIZAWA, K; KIYOSAWA, K; YABU, K; USUDA, S; SHIMIZU,S; FUJIMORI, Y; MUKAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, S
GASTROENTEROLOGIA JAPONICA, 27(6), 780-784, 1992年

PERFORMANCE OF AN ENZYME-LINKED-IMMUNOSORBENT-ASSAY SYSTEM FOR ANTIBODIES TO HEPATITIS-C VIRUS WITH 2 NEW ANTIGENS (C11/C7)
SAITO, M; HASEGAWA, A; KASHIWAKUMA, T; KOHARA, M; SUGI, M; MIKI, K; YAMAMOTO, T; MORI, H; OHTA, Y; TANAKA, E; KIYOSAWA, K; FURUTA, S; WAKASHIMA, M; TANAKA, S; HATTORI, N
CLINICAL CHEMISTRY, 38(12), 2434-2439, 1992年

IMMUNOSUPPRESSIVE THERAPY PROMOTES THE REPLICATION OF HEPATITIS-C VIRUS, FOLLOWED BY EXACERBATION OF LIVER-DISEASE AFTER DOSAGE REDUCTION OR WITHDRAWAL
NAKATSUJI, Y; KIYOSAWA, K; FURIHATA, K; TANAKA, E; MATSUMOTO, A; SODEYAMA, T; FURUTA, S; MAKUUCHI, M
Hepatology, 16(4), A215-A215, 1992年

PERSISTENCE OF VIREMIA IN PATIENTS WITH TYPE-C CHRONIC HEPATITIS DURING LONG-TERM FOLLOW-UP
YOUSUF, M; NAKANO, Y; TANAKA, E; SODEYAMA, T; KIYOSAWA, K
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY, 27(9), 812-816, 1992年

NEW HEPATOCELLULAR-CARCINOMA CELL-LINE SUHC-1 ESTABLISHED FROM A PATIENT WITH HEPATITIS-C VIRUS-RNA IN SERUM
YOSHIZAWA, K; KIYOSAWA, K; USUDA, S; YABU, K; NAKATSUJI, Y; YAMADA, S; FURUTA, K; TANAKA, E; SODEYAMA, T; FURUTA, S; KANEKO, S; NAKANE, PK
JAPANESE JOURNAL OF CANCER RESEARCH, 83(8), 871-877, 1992年

DETECTION OF CHRONIC HEPATITIS-C VIRUS-INFECTION BY 4 DIAGNOSTIC SYSTEMS - 1ST-GENERATION AND 2ND-GENERATION ENZYME-LINKED-IMMUNOSORBENT-ASSAY, 2ND-GENERATION RECOMBINANT IMMUNOBLOT ASSAY AND NESTED POLYMERASE CHAIN-REACTION ANALYSIS
NAKATSUJI, Y; MATSUMOTO, A; TANAKA, E; OGATA, H; KIYOSAWA, K
Hepatology, 16(2), 300-305, 1992年

HEPATITIS-VIRUS INFECTION (HBV AND HCV) IN 11 JAPANESE HEMODIALYSIS UNITS
OGUCHI, H; MIYASAKA, M; TOKUNAGA, S;HORA, K; ICHIKAWA, S; OCHI, T; YAMADA, K; NAGASAWA, M; KANNO, Y; AIZAWA, T; WATANABE, H; YOSHIZAWA, S; SATO, K; TERASHIMA, M; YOSHIE, T; OGUCHI, S; TANAKA, E; KIYOSAWA, K; FURUTA, S
CLINICAL NEPHROLOGY, 38(1), 36-43, 1992年

PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN JAPANESE SCHOOLCHILDREN - COMPARISON WITH ADULT-BLOODDONORS
TANAKA, E; KIYOSAWA, K; SODEYAMA, T; HAYATA, T; OHIKE, Y; NAKANO, Y; YOSHIZAWA, K; FURUTA, S; WATANABE, Y; WATANABE, I; NISHIOKA, K
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 46(4), 460-464, 1992年

HIGH PREVALENCE OF ANTIBODY TO HEPATITIS-C VIRUS IN HEAVY DRINKERS WITH CHRONIC LIVER-DISEASES IN JAPAN
SHIMIZU, S; KIYOSAWA, K; SODEYAMA, T; TANAKA, E; NAKANO, M
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, 7(1), 30-35, 1992年

HEPATITIS-C IN HOSPITAL EMPLOYEES WITH NEEDLESTICK INJURIES
KIYOSAWA, K; SODEYAMA, T; TANAKA, E; NAKANO, Y; FURUTA, S; NISHIOKA, K; PURCELL, RH; ALTER, HJ
ANNALS OF INTERNAL MEDICINE, 115(5), 367-369, 1991年

EXPRESSION OF HEPATITIS-B SURFACE-ANTIGEN SUBTYPES IN LIVER OF PATIENTS WITH HEPATOCELLULAR-CARCINOMA - COMPARISON OF SUBTYPES IN SERUM AND LIVER
NAKATSUJI, Y; KIYOSAWA, K; TANAKA, E; SODEYAMA, T; HORIGOME, N; KAJIKAWA,S; NAITO, S; AKAHANE, Y
LIVER, 11(3), 176-184, 1991年

INTRAFAMILIAL TRANSMISSION OF HEPATITIS-C VIRUS IN JAPAN
KIYOSAWA, K; SODEYAMA, T; TANAKA, E; SHIMIZU, S; FURUTA, S; MIYAZAKI, Y; AKAHANE, Y; SUZUKI, H
JOURNAL OF MEDICAL VIROLOGY, 33(2), 114-116, 1991年

SIGNIFICANCE OF ANTIBODY TO HEPATITIS-C VIRUS IN JAPANESE PATIENTS WITH VIRAL-HEPATITIS - RELATIONSHIP BETWEEN ANTI-HCV ANTIBODY AND THE PROGNOSIS OF NON-A, NON-B POSTTRANSFUSION HEPATITIS
TANAKA, E; KIYOSAWA, K; SODEYAMA, T; NAKANO, Y; YOSHIZAWA, K; HAYATA, T; SHIMIZU, S; NAKATSUJI, Y; KOIKE, Y; FURUTA, S
JOURNAL OF MEDICAL VIROLOGY, 33(2), 117-122, 1991年

A HIGH PREVALENCE OF ANTIBODY TO THE HEPATITIS-C VIRUS IN PATIENTS WITH HEPATOCELLULAR-CARCINOMA IN JAPAN
NISHIOKA, K; WATANABE, J; FURUTA, S; TANAKA, E; IINO, S; SUZUKI, H; TSUJI, T; YANO, M; KUO, G; CHOO, QL; HOUGHTON, M; ODA, T
Cancer, 67(2), 429-433, 1991年

TRANSITION OF ANTIBODY TO HEPATITIS-C VIRUS FROM CHRONIC HEPATITIS TO HEPATOCELLULAR-CARCINOMA
KIYOSAWA, K; TANAKA, E; SODEYAMA, T; FURUTA, K; USUDA, S; YOUSUF, M; FURUTA, S
JAPANESE JOURNAL OF CANCER RESEARCH, 81(11), 1089-1091, 1990年

INTERRELATIONSHIP OF BLOOD-TRANSFUSION, NON-A, NON-B HEPATITIS AND HEPATOCELLULAR-CARCINOMA - ANALYSIS BY DETECTION OF ANTIBODY TO HEPATITIS-C VIRUS
KIYOSAWA, K; SODEYAMA, T; TANAKA, E; GIBO, Y; YOSHIZAWA, K; NAKANO, Y; FURUTA, S; AKAHANE, Y; NISHIOKA, K; PURCELL, RH; ALTER, HJ
Hepatology, 12(4), 671-675, 1990年

PREVALENCE OF ANTI-HCV ANTIBODY IN BLOOD-DONORS IN THE TOKYO AREA
WATANABE, J; MINEGISHI, K; MITSUMORI, T; ISHIFUJI, M; OGUCHI, T; UEDA, M; TOKUNAGA, E; TANAKA, E; KIYOSAWA, K; FURUTA, S; KATAYAMA, T; KUO, G; CHOO, QL; HOUGHTON, M; NISHIOKA, K
VOX SANGUINIS, 59(2), 86-88, 1990年

COMPARATIVE-STUDY OF CLINICAL, HISTOLOGICAL, AND IMMUNOLOGICAL RESPONSES TO INTERFERON THERAPY IN TYPE-NON-A, TYPE-NON-B, AND TYPE-B CHRONIC HEPATITIS
NAKANO, Y; KIYOSAWA, K; SODEYAMA, T; TANAKA, E
AMERICAN JOURNAL OF GASTROENTEROLOGY, 85(1), 24-29, 1990年

C型肝炎のおはなし
田中榮司
シスメックス株式会社, 1-14 2019年

B型肝炎のおはなし
田中榮司
シスメックス株式会社, 1-14 2019年

日本肝臓学会（監修）, 西口修平（監修）, 上野義之, 日浅陽一, 榎本平之(編):肝硬変の成因別実態
杉浦亜弓, 城下智, 髙橋芳之, 栗林直矢, 山崎智生, 藤森尚之, 梅村武司, 松本晶博, 田中榮司, 長野県における肝硬変の成因実態
医学図書出版, 東京, 80-81 2019年

金井正光編：臨床検査法提要第32版
田中栄司, Ⅲ肝・胆道機能検査
金原出版，東京, pp 1335-1387 2005年

林紀夫編：ウィルス性肝炎　消化器3
田中栄司, 急性肝炎の診断と治療（各論）（5）その他のウィルス性急性肝炎
最新医学社，大阪, pp 106-114 2005年

犬山シンポジウム記録刊行会編：ウイルス肝炎からの発癌とその予防
清澤研道，松本晶博，田中榮司，犬山肝炎研究グループ, B型慢性肝炎に対するラミブジン治療調査報告
アークメディア，東京, pp 159-165 2005年

林紀夫編：ウィルス性肝炎　消化器3
松本晶博，田中榮司，清澤研道, B型慢性肝炎の予後（治療による発癌抑止)
最新医学社，大阪, pp 171-176 2005年

高久史麿，猿田亨男，北村惣一郎，福井次矢編：家庭医学大全科
田中栄司, 肝臓の病気/肝炎　C型急性肝炎　C型慢性肝炎　B型漫性肝炎
法研，東京, pp 2023-2029 2004年

二ノ宮節夫，冨士川恭輔，越知隆弘，国分正一，岩谷力編：今日の整形外科治療指針第5版
田中栄司, 術後肝障害の対策
医学書院，東京, pp 32-32 2004年

各務伸一編：コンセンサス2004肝疾患治療
田中栄司, C型肝炎治療の総論
アークメディア，東京, pp 77-83 2004年

林　紀夫，岡上　武，熊田博光編：C型慢性肝炎治療の新たなストラテジー(インターフェロン治療の今後)
田中栄司, C型慢性肝炎の治療とウイルスマーカー
先端医学社，東京, pp 51-57 2004年

清澤研道編：ナースのための肝炎看護ハンドブック　C型肝炎対策を中心に
田中栄司, C型肝炎の検査法
医薬ジャーナル社，東京, pp 33-41 2004年

清澤研道編：ナースのための肝炎看護ハンドブック　C型肝炎対策を中心に
田中栄司, C型肝炎の治療
医薬ジャーナル社，東京, pp 42-53 2004年

犬山シンポジウム記録刊行会編：B型・C型肝炎の病態と治療（第24回犬山シンポジウム）
清澤研道，田中榮司，松本晶博，熊田博光，小俣正男, Lamivudine　治療はB型肝炎の自然経過を修飾するか
アークメディア，東京, pp 3-9 2003年

熊田博光編：医学のあゆみ
田中榮司, ウイルス性肝炎の現況　SENウイルスとその臨床的意義
医歯薬出版，東京, pp 31-34 2003年

山口惠三，岩本愛吉編：日本臨床
田中榮司, グローバル時代の感染症学　ウイルス感染症　ウイルス性肝炎　E型肝炎
日本臨床社，東京, pp 249-253 2003年

石橋大海編：今月の治療
田中榮司, 慢性肝炎の治療と肝炎ウイルスマーカー
総合医学社，東京, pp 1105-1108 2003年

Hepatitis C virus in the etiology of hepatocellular carcinoma. Tabor E: Virus and Liver Cancer
Kiyosawa K, Tanaka E
Elsevier, pp 31-42 2002年

Hepatocellular carcinoma and Hepatitis C. Sarin SK. Okuda K: Hepatitis B and C carrier to cancer
Kiyosawa K, Tanaka E
ELSEVIER INDIA, pp 315-329 2002年

Ｃ型肝炎，自然経過と予後．矢野右人，林紀夫，沖田極編：コンセンサス肝疾患2002診断・治療と病態
田中榮司
日本メディカルセンター, pp 114-123 2002年

Ｃ型肝硬変の生体肝移植．熊田博光編：Ｃ型慢性肝炎の治療最前線ー最近の知見と治療ー
田中榮司
メディカルレビュー社, pp 222-227 2002年

新しいHBV定量系HBVコア関連抗原(HBcrAg)の臨床的応用性．犬山シンポジウム記録刊行会編：B型・C型肝炎治療の新たな展開
六波羅明紀，田中榮司，松本晶博，木村達治，八木慎太郎，槇昇，清澤研道
アークメディア, pp 15-19 2002年

米国肝臓学会

日本癌学会

日本ウイルス学会

日本消化器内視鏡学会

重症肝疾患の肝移植

B型肝炎の抗ウイルス療法

C型肝炎の抗ウイルス療法

自己免疫性肝疾患の遺伝的背景

B型肝炎の再活性化

脂肪性肝疾患の診断と治療

HBV-RNAを含むHBV粒子, 2003-83283, 特許権

B型肝炎ウイルスの薬物抵抗性を識別する方法, 2004-558464, 特許権

C型慢性肝炎の治療効果を事前に予測するためのキット, 8-167497, 特許権

競合PCR法による核酸の簡易定量法, 6-71701, 特許権